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Exosomes released by myeloid-derived suppressor cells (MDSC) are 30 nm in 
diameter extracellular vesicles that have been shown to carry biologically active 
proteins as well as ubiquitin molecules.  Ubiquitin is known to have many functions, 
including involvement in the formation of exosomes, although the exact role is highly 
contested.  In the study reported here, the proteome and ubiquitome of MDSC 
exosomes has been investigated by bottom-up proteomics techniques.  This report 
identifies more than 1000 proteins contained in the MDSC exosome cargo and 489 
sites of ubiquitination in more than 300 ubiquitinated proteins based on recognition of 
glycinylglycine tagged peptides without antibody enrichment.  This has allowed 
extensive chemical and biological characterization of the ubiquitinated cohort 
compared to that of the entire protein cargo to support hypotheses on the role of 
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 The field of mass spectrometry began with JJ. Thomson, who constructed the 
first mass spectrometer and discovered two isotopes of neon at the beginning of the 
twentieth century.
1
 Numerous advances and Nobel Prizes later, mass spectrometry is 
an invaluable technique utilized in all parts of science and technology, especially the 
analysis of biomolecules.  There are many different biomolecules that utilize mass 
spectrometry for characterization including proteins, oligonucleotides, 
oligosaccharides, lipids, and metabolites.  Proteomics is the study of proteins in a 
proteome, including identification and quantification.
2
  Proteins and peptides are 
complex biopolymers made up of the 20 amino acids and may also undergo covalent 
modifications or post-translational modifications, PTMs.  Common PTMs include 
glycosylation, phosphorylation, acetylation, and ubiquitination.  In order to identify 
and characterize proteins and peptides in samples, precise determination of molecular 
mass is needed to determine sequences and mass additions for post-translational 
modifications.   
 The initiation step in mass spectral analysis is the ionization of the sample 
molecules of interest.  The challenge with biological samples, including proteins and 




without degradation, loss of modifications, or unwanted fragmentation.
3
  The earliest 
ionization techniques, electron ionization (EI) and chemical ionization (CI), required 
volatile analytes, and therefore could not be employed for heavy biomolecules.  
Electrospray ionization, ESI, was developed by John Fenn in 1988 and allowed 
nonvolatile molecules to be easily ionized so they could be analyzed by mass 
spectrometry.
3
  Ions are created by flowing solution through a heated narrow metal 
capillary which has an electric potential.  This generates a fine mist of ions that are 
sprayed into the inlet of the mass spectrometer.
4
  Nanoelectrospray ionization, nESI, 
was developed from ESI in 1994 by M. Wilm and M. Mann.
1
  The nESI technique 
uses a decreased flow rate to more efficiently create ions, improve sensitivity, and 
reduce sample size.
3
   
 Protein and peptide biological samples are usually complex and require 
separation techniques before mass spectral analysis.  Pre-fractionation helps with 
more accurate mass determination and fragmentation; if samples are too complex 
entering into the mass analyzer, many important ions can be missed and not 
accurately measured.
1
  Additionally, high concentrations of background molecules in 
biological samples can decrease ionization efficiency and effectively shield detection 
of ions of interest.  Some common pre-fractionation techniques for proteins and 
peptides include SDS-Page, size exclusion chromatography, ion exchange 
chromatography, and reverse phase liquid chromatography (RP-HPLC).
5
  RP-HPLC 
is one of the most popular pre-fractionation techniques and is used to concentrate, 
desalt, and simplify mixtures before mass spectral analysis.  RP-HPLC can be 




phases are volatile and compatible with ESI and nESI.  LC-MS workflows decrease 
sample loss, as fractionated sample is eluted from the column directly into the mass 
spectrometer.   
Tandem mass spectrometry (MS/MS) is commonly used in proteomic 
workflows as it gives important fragmentation and sequence information about 
proteins and peptides.  A precursor ion is first isolated for activation and 
fragmentation, and the subsequent product ions are then measured.  For proteins and 
peptides, fragmentation occurs mostly along the peptide backbone and yields 
information to sequence peptides and intact proteins.  Collision-induced dissociation 
(CID) is the most common technique for fragmenting peptides and proteins.
6
  Neutral 
gas molecules are introduced to the reaction cell and collide with the precursor ions.  
The energy transferred during collision cleaves along the weakest point in the peptide 





Figure 1.1. Representative of the fragmentation and ion types that can occur along 




 Other types of fragmentation are higher energy CID, commonly termed HCD, 
that utilizes higher energy collisions for fragmentation and can produce a/x type ions 
along with b/y ions (green in Figure 1.1).
1
  Electron transfer dissociation, ETD, uses a 
negative reagent ion to effectively transfer an electron to the precursor ion and create 
c/z type ions (red in Figure 1.1).  ETD requires higher charged precursor ions for 




 The measurement and analysis of intact proteins is referred to as top-down 
proteomics.  This method is advantageous for identifying protein isoforms in 
biological samples and characterizing sites and types of PTMs.
1,9
  Currently there are 
many limitations in top-down experiments.  Analysis of intact proteins relies on 
accurate mass measurements and fragmentation information for sequencing.  Large 
proteins have lesser ionization and transfer efficiency in mass spectrometers and 
extensive fragmentation is needed for sequencing and accurate PTM assignment.  
Additionally, many instruments are limited by the mass range they can separate and 
analyze.  Top-down experiments require MS instruments with improvements in mass 
resolving power and fragmentation methods.
10
     
  Bottom-up proteomics is the most widely used method of characterizing 
proteins by analyzing their peptides.  In these experiments, proteins of interest are 
first digested into peptides.  There are many enzymes in nature that cleave along the 
peptide backbone at specific and reproducible residues to create smaller peptides.  
The most commonly used enzyme is trypsin, which cleaves along the peptide 




peptides commonly 7 to 35 amino acids in length.
11
  Protein identifications are made 
by using fragmentation information to sequence and identify peptides, which are then 
searched against protein databases to identify the original protein.
2
  This method is 
advantageous as the size of peptides is amenable to most available instruments and 
the bioinformatics search engines for analyzing peptide spectra are well developed.
12
   
1.1.2 Orbitrap Fusion Lumos Tribrid 
 Development of the orbitrap mass analyzer has allowed for the field to 
progress rapidly in the past two decades.  The first orbitrap based instrument was 
presented in 1999 at the American Society for Mass Spectrometry national 
conference, but would not be commercialized until 2005.
13
  There have been seven 
instruments in the orbitrap family released by Thermo Scientific since 2005, featuring 
improvements in coupled ionization sources, activation abilities, and added speed and 
resolving power.
1,13
  Based off the principle of orbital trapping designed by Kingdon 
in 1923, the orbitrap utilizes three distinct electrodes.
13
  The outer two electrodes are 
positioned around a spindle-like central electrode and mass to charge measurements 
are based off the frequency of ions’ movement along the length of the central 
electrode.  
 The orbitrap Fusion Lumos Tribrid mass spectrometer was released by 
Thermo Scientific in 2015.  A schematic is shown in Figure 1.2.  This new generation 
orbitrap mass spectrometer has increased sensitivity and acquisition speed with an 
ultra-high field orbitrap and improved vacuum systems.  This improved orbitrap mass 
analyzer has a resolving power of up to 450,000 at 200 m/z and the vacuum system 




more efficient ion transfer through the instrument.
13,14
  Increases in acquisition speed 
and duty cycle also stem from the ion routing multipole (IRM) cell.  The IRM cell 
controls where packets of ions are being sent for activation or for measurement, 
allowing ions to be isolated in one analyzer while separately detecting ions in the 
remaining analyzers of the dual-pressure linear ion trap.
14
  This increases sensitivity 
for lower abundant ions by allocating analysis time for ion accumulation while 












1.2 Biological question 
1.2.1 Exosome biogenesis and function 
 Exosomes, by definition, are 30-100 nm extracellular vesicles released by all 
cell types.
15–17
  They are widely studied because they carry protein and small RNA 
cargo important to the biological function of the parental cells and convey 
information from the parental cell to a receiving cell or location.
18
  They are under 
development as vehicles for drug delivery.
19
  Exosomes are formed by the 
invagination of endosomal membranes forming multivesicular bodies (MVB) that 
form intraluminal vesicles (ILV) as shown in Figure 1.3.
18
  There are two fates of 
these MVBs, fusion with lysosomes leading to the degradation of their protein cargo 
or fusion with the plasma membrane to release the ILVs as exosomes.
16,20–23
  
Exosome biogenesis may vary within a cell and between cell types, and investigations 





Figure 1.3. Illustration of the formation of MVBs and ILVs, and their pathway to 






The protein cargo of exosomes is not random; incorporation of proteins into 
exosomes has been shown to be a regulated process, which usually reflects functions 
of the parent cell.
16,22
 The endosomal sorting complex required for transport, or 
ESCRT complex, has been shown to mediate the formation of MVBs and protein 
cargo sorting.  It has been shown to cluster ubiquitinated proteins into ILVs destined 
for degradation by the lysosome as  ESCRT-0, -I, and -II proteins contain ubiquitin 
binding domains that interact with ubiquitinated cargo.
16,23–25
  Ubiquitination is 
hypothesized to have an important role in MVB fate and exosome formation, and 
additionally it has been reported that there are ubiquitinated proteins contained in 
exosomes of different cell types.
21,26–28
   
1.2.2 Ubiquitin as a post-translational modification 
Ubiquitin is a small 8.5 kDa protein that can be found as mono- or 
polyubiquitin in cells either unanchored or conjugated to a protein substrate.  
Conjugation is formed through an isopeptide bond at its C-terminal glycine-76 with 
the ε-amine of a lysine (K) residue in another ubiquitin or a substrate protein.  
Ubiquitin conjugation occurs through the coordination of three families of enzymes 
and is regulated by hydrolase enzymes, shown in Figure 1.4.
29










 E1-activating enzymes are the first step in ubiquitin conjugation.  E1’s 
contain an active-site cysteine to which the carboxy-terminal glycine of ubiquitin 
becomes attached through a reactive thioester bond for conjugation of ubiquitin to the 
enzyme.
31,32
  The activated ubiquitin molecule is then transferred to an E2-
conjugating enzyme that is recruited by the E1 enzyme.
31,32
  Lastly, a specific E3 
ligase catalyzes the attachment of the activated ubiquitin to the lysine of the substrate 
protein.
31
   The enzymes increase in complexity and specificity with each additional 
step in the conjugation pathway; there are few E1 enzymes with low specificity that 
conjugate with many E2 enzymes, and hundreds of E3 ligases with high specificity 




Deubiquitinating enzymes, or ubiquitin hydrolases, reshape ubiquitin 
modifications by shortening polyubiquitin chains or by complete removal of the 
entire modification.
29,33
  These enzymes hydrolyze at the C-terminal Gly76 of 
ubiquitin to remove it from the modified lysine.  Humans have five different families 
of deubiquitinating enzymes; some have broad specificity while others can be 
selective for substrate or for linkage type.
34
  These enzymes are important for 
regulating the production of monomeric ubiquitin by recycling ubiquitin from 
conjugates and the proteasome, and editing polymer chain lengths.
35
 
Ubiquitin itself has seven lysine residues and therefore can form polyubiquitin 
chains at multiple sites and of various linkage types, including chains conjugated at 
the N-terminus of ubiquitin.
36
  There are many different functions proposed for 
ubiquitin and ubiquitin polymers in the cell.
33,36
   Monoubiquitin, ubiquitin 
conjugated to a single lysine, is thought to be involved in protein localization, 
transcriptional activation and chromatin structure.
29
  Multi-monoubiquitin, ubiquitin 
conjugated to multiple individual lysines in a single protein, may assist with ubiquitin 
binding to low affinity ubiquitin-interacting domains and adapter proteins’ 
recognition of substrate proteins.
28
  There are seven “linear” polyubiquitins, in which 
each ubiquitin chain is attached to an analogous lysine of another chain, and hundreds 
of mixed and branched linkage polymers that could be formed.  However, not all 
types have been isolated in vivo or in vitro, and not all have known functions.
16,29,37
  
The K48-linked tetramer polyubiquitin is well studied for its involvement in the 26S 
proteasome and the most well-known function of ubiquitination is as a protein tag for 
disposal.
28,38




lysosomal degradation and K-11 linked polyubiquitin involvement in endoplasmic 
reticulum-associated degradation.
36
  Ubiquitin may have signaling roles in other 
pathways besides degradation; many studies also suggest the importance of ubiquitin 
in kinase activation, DNA repair, ribosome function, and cell signaling.
16,29,31
  
Interestingly, there have been many recent studies on the importance of ubiquitinated 
proteins in the formation of exosomes.
20
  For example, K-63 linked polyubiquitin is 




1.2.3 The role of ubiquitin in exosome formation 
Ubiquitin is hypothesized to be an important player in determining the fate of 
MVBs, but the exact roles are still disputed.  There is strong evidence that 
ubiquitination is involved in invagination, the first step in MVB formation.
20
  
Ubiquitination is also reported to be an important tag for sorting proteins into MVBs 
destined to be degraded by the lysosome.
25,40
  The ESCRT complex, specifically 
ESCRT-I, -II, and –III, has been shown to deactivate proteins by monoubiquitin 
addition and to cluster these tagged proteins into ILVs destined for the lysosome.
23,25
  
There are recently reported studies that show that ubiquitination may also 
influence formation of exosomes in MVBs, but there is still disagreement about how 
ubiquitin signaling occurs and whether there should be any ubiquitinated proteins 
present within MVBs and exosomes.  One hypothesis is that protein sorting into 
exosomes happens through deubiquitination of the proteins before addition to the 
MVBs, thus preventing transport into the lysosomes.
33
  Amerik et al. reported 




ubiquitin tags from cargo prior to incorporation into newly forming MVBs.
41
   
Conversely, Buschow et al. hypothesize that deubiquitination occurs before 
incorporation into the MVB for the lysosome pathway, and it is the proteins that 
escape deubiquitination that are sorted into ILVs destined to be released as 
exosomes.
21
  Huebner et al. also propose that deubiquitination is not essential for the 
protein cargo to be incorporated into MVBs destined to be released as exosomes.
28
   It 
should be noted that ubiquitinated proteins have been identified in urinary exosomes 
and exosomes released from human B-cells, murine immature dendritic cells, and 
murine myeloid-derived suppressor cells.
21,26,28
  Ubiquitination has been shown to be 
important for trafficking in some cell types but not others.
16
  This indicates that 
different cell types have their own specific functions and regulators, and different cell 
types need individual study as not all assumptions will hold across cell types. 
 
1.3 Research objectives and significance 
 Ubiquitin is widely studied as an important protein post-translational 
modification and it has many suggested functions in the cell.  The aim of my research 
is to investigate the ubiquitome of exosomes secreted by myeloid-derived suppressor 
cells (MDSC) collected directly from tumor-bearing mice.  MDSC-exosomes are 
interesting biological samples as the parental cells block innate and acquired immune 
responses in the tumor microenvironment.
42
  The MDSCs are collected from animals 
with elevated inflammation and are under considerable cellular stress at the time of 
exosome release.
43




highly contested, and identification of the ubiquitinated proteins in exosomes may 
provide insight into this role.   
 For this project, the first objective is to provide an in depth inventory of the 
proteome of the MDSC exosomes utilizing the orbitrap Fusion Lumos Tribrid mass 
spectrometer with tryptic digestion and HPLC separation.  The second objective is to 
utilize the same sensitive tryptic and LC-MS/MS strategy to also identify the 
ubiquitinated proteins in the exosomes.  By first inventorying the larger proteome of 
this biological sample, the ubiquitinated cohort can be compared to look for insights 













Myeloid-derived suppressor cells, MDSC, congregate in the tumor 
microenvironment of individuals and mice with cancer.  Under inflammatory 
conditions, which are prevalent in many solid tumors, these cells increase tumor 
growth by a variety of mechanisms including preventing the activation of tumor-
reactive T lymphocytes and polarizing macrophages towards a M2 tumor-promoting 
phenotype.
42,43
  MDSCs produce reactive oxygen species and reactive nitrogen 
species in the tumor microenvironment, creating an environment of oxidative sress.
43
  
MDSC accumulation and function are driven by pro-inflammatory molecules and 
other tumor-secreted factors that are present in the microenvironment.  Chemotaxis 
migration assays are used to study environmental effects to MDSC function, and it 
has been shown that both S100-A8 and S100-A9 activity is important for migration of 
MDSC.
44
  MDSC also release exosomes that show significant chemotactic activity 
towards other MDSCs, catalyzing their migration into the tumor environment.
44–46
   
Exosomes are small (30-100 nm) secreted extracellular microvesicles 
involved in the transport of bioactive molecules between cells.
15
  Exosomes are 
secreted by all cell types and can be isolated from nearly all tissue samples and 
physiological fluids.
16,17
  They have been shown to carry proteins, small RNAs, and 






  Exosomes are formed by invagination of the limiting membrane of 
specific endosomal compartments, multivesicular bodies (MVBs), that form 
intraluminal vesicles (ILVs) that once fused with the plasma membrane are released 
as exosomes.
16,21–23
  Protein sorting into exosomes is not random.  The endosomal 
sorting complex required for transport (ESCRT complex) has been shown to play a 
role in the formation of MVBs and protein sorting by clustering ubiquitinated proteins 
into ILVs.
16,23,25
  However, the exact mechanisms for sorting cargo is not yet known.  
Furthermore, the cargo carried by exosomes has received considerable attention for 
its potential and demonstrated intercellular bioactivities.  
MDSC-derived exosomes are 25-30 nm in diameter, as measured by 
Transmission electron microscopy by Burke et al., and have been shown to contain 
bioactive proteins including the calcium- and zinc-binding pro-inflammatory proteins 
S100-A8 and -A9, histones, and other nucleic acid binding proteins.
44 
   A recent 
study by Burke et al. sought to identify proteins differentially expressed between two 
types of MDSC-derived exosomes.  This work was successful in identifying over 400 
proteins in the exosomes and differential expression of proteins involved in innate 
immune response, cytoskeletal proteins, chemotactic proteins, and nucleotide binding 
proteins.
44
  Additionally, chemotaxis assays confirmed the hypothesis that MDSC-
derived exosomes support MDSC functions in the tumor microenvironment.
44





2.2 Materials and methods 
2.2.1 Materials 
 All materials and chemicals were purchased from Sigma Aldrich (St. Louis, 
MI) unless otherwise stated. 
2.2.2 Biological sample preparation 
MDSC-derived exosomes were isolated and purified by methods described by 
Burke et al. (2014).
26
  Exosomes were stored at -80 °C until use.  All procedures with 
animals and animal-derived materials were approved by the UMBC and UMCP 
Institutional Animal Care and Use Committees.   
2.2.3 Protein analysis 
Exosomes were lysed in an optimized lysis buffer of 8 M urea in 50 mM 
ammonium bicarbonate with 50 uM deubiquitinase inhibitor PR-619 (LifeSensors, 
Malvern, PA) and 1% protease inhibitor cocktail.  The solution was centrifuged at 
13,000 g for 30 minutes at room temperature in 3 kDa molecular weight cut off filters 
(Millipore, Darmstadt, Germany), and the filtrate was discarded.  This process was 
performed three times.  After filtration, the protein was recovered in 0.8 M urea in 50 
mM ammonium bicarbonate for subsequent analyses.  Protein content was measured 
using the Pierce BCA Assay Kit (Thermo Scientific, Waltham, MA). 
Tryptic digestion was performed in solution using 25 ug of protein lysate.  
Samples were reduced with 20 mM dithiothreitol (DTT) for 30 min at 56 °C and 
alkylated with 10 mM methyl methanethiosulfonate (MMTS) for 45 min.  Trypsin 




and digestion was performed overnight at 37 °C and stopped with the addition of 
0.1% formic acid.  Three technical replicates of 1 ug total protein were analyzed by 
LC-MS/MS for each of three biological replicates. 
2.2.4 LC-MS/MS and bioinformatics 
LC-MS/MS analyses were performed on an Ultimate 3000 nano-HPLC 
system (Dionex, Sunnyvale, CA) in-line with an orbitrap Fusion Lumos Tribrid mass 
spectrometer (Thermo Scientific).  A 2 uL aliquot of tryptic peptide solution was 
injected onto a C18 precolumn (Dionex, Sunnyvale, CA) followed by desalting with 
90% solvent A (97.5% H20, 2.5% ACN, and 0.1% formic acid) for 10 minutes.  
Peptides were fractionated on a C18 column (Dionex, Sunnyvale, CA) with a 2 hour 
linear gradient at a flow rate of 300 nL/min increasing from 5 to 55% solvent B 
(97.5% ACN, 2.5% H2O, and 0.1% formic acid) in 90 minutes, followed by an 
increase from 55 to 90% solvent B in 5 minutes, and held at 90% solvent B for 5 
minutes.   Precursor scans were acquired in the orbitrap with a resolution of 120,000 
at m/z 200.  The most abundant ions, as many as possible, were selected for 
fragmentation by CID (35% collision energy) in the ion trap during each 3 second 
duty cycle, and product ion scans were acquired in the ion trap.  A dynamic exclusion 
of 1 repeat count over 30 seconds was used.   
Peptide and protein identifications were made by the PepArML
48,49
 meta-
search engine against the UniProt mouse database (01 2015).  Peptide identifications, 
including decoy identifications resulting from searching a reversed protein sequence 
database, were filtered at 10% spectral FDR. Proteins with at least two unique 




protein FDR as ≤ 0.87%, after correction using the MAYU technique.
50
  Fixed 
modifications listed methylthio modification of cysteine, and variable modifications 
included oxidation of methionine, Gln to pyro-Glu, Glu to pyro-Glu, pyro-
carbamidomethyl, and glycinylglycine modification of lysine.  Subcellular location 
and function assignments of the identified proteins were made using the Protein 
Information Resource GO Slim (http://pir.georgetown.edu) and UniProt Gene 
Ontology annotations (05 2016).  Hydrophobicity and chemical characteristics were 
analyzed using the ExPASy Bioinformatics Resource Portal ProtParam.
51
 











2.3 Results and discussion 
One thousand sixteen proteins were identified in the exosome lysate by 
bottom-up analysis with tryptic digestion, and are listed in Appendix Table 1.  
Previously, whole exosome lysate analyses by bottom-up have identified 412 proteins 
contained in the MDSC exosomes.
44
  This updated inventory holds many functionally 
important proteins and allowed for extensive chemical and biological 
characterization.  Multiple proteins reported as being characteristic of exosomes
18
 
were identified including 7 annexins (A1, A2, A3, A, A7, A11), 5 tetraspanins, heat 
shock 70 kDa protein 4, heat shock cognate 71 kDa, and HSP 90 alpha and beta, 
listed in Table 2.1.  Additionally, five S100 family proteins, also listed in Table 2.1, 
were identified in this sample: S100-A6, -A8, -A9, -A11, and -A13.  S100-A8 and -
A9 can form an active heterodimer and S100-A8 is present with numerous isoforms 
in MDSC exosomes.
52
  S100-A8 and -A9 have previously been shown to be 
chemotactic.
44,53,54
  The content of S100-A8 and –A9 in MDSC exosomes plays a role 
in exosome mediation of MDSC chemotaxis in the tumor microenvironment.
44


















P10107 Annexin A1  16 64.5% 
P07356 Annexin A2  14 59.9% 
O35639 Annexin A3  15 63.2% 
P48036 Annexin A5  8 37.9% 
P14824 Annexin A6  10 22.3% 
Q07076 Annexin A7  7 23.3% 
P97384 Annexin A11  12 29.8% 
P10810 CD14  3 13.4% 
P40237 CD82  2 8.7% 
Q9Z0M6 CD97  4 8.1% 
Q64277 CD157 2 7.1% 
Q8R2S8 CD177  12 21.5% 
Q3U2G2 Heat shock 70 kDa protein 4  17 33.1% 
P63017 Heat shock cognate 71 kDa 
protein  
30 73.4% 
P07901 Heat shock protein HSP 90-
alpha  
24 48.3% 
P11499 Heat shock protein HSP 90-beta  23 50.4% 
P14069 Protein S100-A6  6 80.9% 
P27005 Protein S100-A8  5 94.4% 
P31725 Protein S100-A9  8 83.2% 
P50543 Protein S100-A11  2 27.6% 
P97352 Protein S100-A13  2 14.4% 
 
Gene ontology annotations of the proteins identified in the exosomes indicate 
that 24% of the proteins are involved in protein binding and 16% in ion binding 
molecular functions, Figure 2.2a.  The five S100 proteins identified contribute to the 
latter category.  Three of the top 5 molecular function categories are related to nucleic 
acid binding (nucleic acid binding, nucleotide binding, and nucleoside binding).  
Additionally, GO cellular locations, Figure 2.2b, annotate 16% of the identified 




transcription factors.  Numerous other studies have identified many nucleic acid 
binding proteins in extracellular vesicles.
27,44
   
 
 
Figure 2.2a-b. Gene ontology annotations of the (a) molecular functions and (b) cellular 





 The compilation of isoelectric points, pI, shows a distribution through the 
range of pH 3 to 12 with the greatest abundance between pH 5 and 6.5, as seen in 
Figure 2.3a.  The pI distribution of the MDSC exosome proteome was compared to 
that of the whole mouse proteome, and the pI distribution of the exosome proteome is 
slightly more acidic than that of the mouse proteome, as seen in Figure 2.3b.  The 
molecular weight distribution of the identified proteins shows the highest frequency 
of proteins around 50 kDa, as seen in Figure 2.4.  The four largest proteins identified 
are nesprin-1 (Acc. No. Q6ZWR6, MW=1,009,925.81 Da), E3 ubiquitin-protein 
ligase UBR4 (A2AN08, MW=572,289.85 Da), plectin (Q9QXS1, MW=534,187.76 
Da), and cytoplasmic dynein 1 heavy chain 1 (Q9JHU4, MW=531,914.24 Da).  The 
grand average of hydropathy, GRAVY, scores of the exosome lysate show an uneven 
distribution of more hydrophilic proteins, as seen in Figure 3.3a.  These distributions 





Figure 2.3a-b. Chemical characteristics analyses including (a) isoelectric point, pI, 
distribution of the proteins identified in the exosome lysate and (b) comparison of the 






Figure 2.4. Molecular weight distribution of the proteins identified in the MDSC 
exosomes; inset shows the 0 - 350,000 Da range. 
 
 
Thirty subunits of the 26S proteasome were identified in MDSC exosomes, all 
listed in Table 2.2, encompassing all but 4 of the 34 known components in mice.
55
  
Some components of the 26S proteasome have been previously identified in 
exosomes.
44,56
  Recently, Huebner et al. identified 36 of the 37 human components
57
 
in urinary exosomes and Zhu et al. reported identifying 33 components in exosomes 
released from murine tumor-associated macrophages.
28,58
  Zhu et al. also performed a 
20S proteasome activity assay that indicated that the tumor-associated macrophage 
exosomes have proteolytic activity.
58













Q3TXS7 26S proteasome non-ATPase regulatory subunit 1  14 29.9% 
Q8VDM4 26S proteasome non-ATPase regulatory subunit 2  23 43.5% 
P14685 26S proteasome non-ATPase regulatory subunit 3  11 36.2% 
Q8BJY1 26S proteasome non-ATPase regulatory subunit 5  4 13.9% 
Q99JI4 26S proteasome non-ATPase regulatory subunit 6  8 29.3% 
P26516 26S proteasome non-ATPase regulatory subunit 7  8 53.0% 
Q9CPS5 26S proteasome non-ATPase regulatory subunit 8  2 15.9% 
Q8BG32 26S proteasome non-ATPase regulatory subunit 11  9 32.9% 
Q9D8W5 26S proteasome non-ATPase regulatory subunit 12  7 18.0% 
Q9WVJ2 26S proteasome non-ATPase regulatory subunit 13  10 47.9% 
O35593 26S proteasome non-ATPase regulatory subunit 14  6 41.3% 
P62192 26S protease regulatory subunit 4  6 23.0% 
O88685 26S protease regulatory subunit 6A  10 40.1% 
P54775 26S protease regulatory subunit 6B  9 42.3% 
P46471 26S protease regulatory subunit 7  6 22.2% 
Q8K1K2 26S protease regulatory subunit 8  5 23.3% 
P62334 26S protease regulatory subunit 10B  6 26.0% 
Q9R1P4 Proteasome subunit alpha type-1  10 56.3% 
O70435 Proteasome subunit alpha type-3  5 23.1% 
Q9R1P0 Proteasome subunit alpha type-4  8 57.5% 
Q9Z2U1 Proteasome subunit alpha type-5  7 45.2% 
Q9QUM9 Proteasome subunit alpha type-6  10 52.0% 
Q9Z2U0 Proteasome subunit alpha type-7  8 47.2% 
O09061 Proteasome subunit beta type-1  9 58.8% 
Q9R1P3 Proteasome subunit beta type-2  7 64.2% 
Q9R1P1 Proteasome subunit beta type-3  5 40.5% 
P99026 Proteasome subunit beta type-4  8 55.7% 
O55234 Proteasome subunit beta type-5  7 40.9% 
Q60692 Proteasome subunit beta type-6  8 65.6% 
P70195 Proteasome subunit beta type-7  9 55.2% 
 
The present study has identified evidence for polyubiquitins in the exosome 
lysate, to be discussed in greater detail in Chapter 3.  We have also identified multiple 




activating enzyme E1 (Q02053) is an enzyme that catalyzes the first step in ubiquitin 
conjugation marking cellular proteins for degradation by the proteasome and is a 
critical component of ubiquitination in DNA repair pathways.
59,60
  Ubiquitin-
conjugating enzyme E2 L3 (P68037) is an ubiquitin-conjugating E2 enzyme that is 
reported to catalyze K-11 linked polyubiquitination in vitro.
61
  Four E3 type ligases 
were identified.  E3 ubiquitin-protein ligase CBL (P22682), ubiquitin-protein ligase 
E3A (E9QKT1), and E3 ubiquitin-protein ligase UBR4 (A2AN08) promote proteins 
for degradation by the proteasome.
62–64
  The latter is also reported to form meshwork 
structures with clathrin (also identified in MDSC exosomes) and may be involved in 
invagination.
22,65
  Probable E3 ubiquitin-protein ligase HERC4 (Q6PAV2) is reported 
to be involved in protein trafficking.
66
   
 









Q02053 Ubiquitin-activating enzyme E1  32 53.8% 
P68037 Ubiquitin-conjugating enzyme E2 L3  3 40.3% 
P22682 E3 ubiquitin-protein ligase CBL  2 3.0% 
A2AN08 E3 ubiquitin-protein ligase UBR4  2 0.8% 
Q6PAV2 Probable E3 ubiquitin-protein ligase HERC4  2 3.5% 
E9QKT1 Ubiquitin-protein ligase E3A  2 3.8% 
P70398 
Probable ubiquitin carboxyl-terminal hydrolase 
FAF-X  5 4.1% 
Q9JMA1 Ubiquitin carboxyl-terminal hydrolase 14  6 19.9% 
P56399 Ubiquitin carboxyl-terminal hydrolase 5  6 13.4% 
D3YWF6 Ubiquitin thioesterase OTUB1  4 30.7% 





Five deubiquitinase enzymes were identified in the exosome lysate, also listed 
in Table 2.3.  Probable ubiquitin carboxyl-terminal hydrolase (P70398) is a 
deubiquitinase thought to favor K-29 and K-33 polyubiquitin chains.
67
 Ubiquitin 
carboxyl-terminal hydrolase 5 (P56399) is reported to have a preference for branched 
chains.
38
  Ubiquitin carboxyl-terminal hydrolase 14 (Q9JMA1) is a proteasomal-
associated deubiquitinase that releases ubiquitin from proteins tagged for the 
proteasome.
35,68,69
  Ubiquitin thioesterase OTUB1 (D3YWF6) and ubiquitin carboxyl-
terminal hydrolase (F8VPX1) are also identified.   
 
2.4 Conclusions 
This study provides an in depth inventory of proteins in MDSC-derived 
exosomes.  Transwell migration studies have previously shown that members of the 
protein cargo of exosomes are biologically active and contribute to parental cell 
functions.
44
  Gene ontology annotations characterize the majority of the lysate as 
protein binding and ion binding, including the pro-inflammatory S100-A8 and –A9 
proteins.  Additionally, nucleic acid binding functions contribute to three top 
molecular function categories, and families of histones, ribosomal proteins, and 
transcription factors have been identified.  MDSC exosomes contain several hundred 
small RNAs (private communication from Lucia Geis Asteggiante) and it may be 
hypothesized that the highly abundant nucleic acid binding proteins act as chaperones 
for this genetic material. 
The components of the 26S proteasome were identified in MDSC exosomes.  




proteasome components in exosomes of different cell type and origin.
28,58
  Large 
numbers of proteasome subunits have not been identified in proteomic analyses of 
most exosomes.  It is not clear if they are only present – and active – in a limited 
selection of exosomes, or if they were missed in many earlier proteomic analyses.   
Three of the ubiquitination enzymes identified, ubiquitin-like modified-
activating enzyme 1, E3 ubiquitin-protein ligase UBR4, and ubiquitin carboxyl-
terminal hydrolase 14, are known to be associated with the 26S proteasome.
59,62,69
  
However, ubiquitin-like modified-activating enzyme 1 has additional roles in the 
cell.
60
  Therefore these results suggest that the status of ubiquitination may be 
dynamic inside the exosomes, as all of the players are present.   
 




Chapter 3: The Ubiquitome 
 
3.1 Introduction 
Ubiquitin is a small 8.5 kDa protein that can be found unanchored in cells or 
conjugated to protein substrates as mono- or poly-ubiquitin.  Conjugation is formed 
through an isopeptide bond at its C-terminal glycine-76 with the ε-amine of a lysine 
residue. Ubiquitination as a post-translational modification is of great interest because 
it imposes a variety of biological functions on substrate proteins, including protein 
degradation, protein trafficking, DNA repair, and invagination.
20,33,37,39,40,70
   There 
have been recent studies disagreeing on the role of ubiquitinated proteins in the 
formation of exosomes from MVBs
21,28,33,41
 as discussed in Chapter 1, however 
ubiquitinated proteins have been identified in exosomes from multiple cell 
types.
21,26,28
   
Ubiquitin as a protein post-translational modification is challenging to study, 
as it is a very large modification and ubiquitinated proteins are usually present at 
substoichiometric levels compared to unmodified proteins.
29,32,39
  There are multiple 
approaches to targeting and identifying ubiquitin and ubiquitinated proteins.  The use 
of cell strains expressing 6xHis-tagged or streptavidin-tagged ubiquitin has been 
successful for quick and efficient purification of ubiquitinated proteins.  For example, 
Peng et al. utilized 6xHis-tagged ubiquitin to detect 110 precise ubiquitination sites in 
72 ubiquitinated proteins from Saccharomyces cerevisiae lysate.
39
  Danielson et al. 
purified streptavidin-tagged ubiquitin by affinity purification and reported 753 unique 
sites on 471 proteins from a human U2OS osteosarcoma cell line.
32




require the use of transfected cell lines and are unsuitable for animal tissues or 
clinical samples.
29
   
Anti-ubiquitin antibodies are commercially available to detect ubiquitin and 
ubiquitin-modified proteins in cell lysate samples by western blotting and more 
limitedly by immunoprecipitation and co-immunoprecipitation.  Ubiquitin-remnant 
profiling K- ε -GG antibodies have been used successfully to enrich peptide samples 
after tryptic digestion and allowed Xu et al.  to identify 374 sites on 236 proteins 
from HEK293 cells using this technique.
71
  Both ubiquitin-specific antibody 
enrichment methods, general anti-ubiquitin antibody enrichment followed by tryptic 
digestion and subsequent ubiquitin remnant profiling, have been utilized by Burke et 
al. to compile a list of 50 ubiquitinated proteins in MDSC-derived exosomes.
26
  It has 
been reported that most anti-ubiquitin antibodies have limited and differential 
affinities for ubiquitin-modified proteins as substrates, and therefore these enrichment 
methods may produce biased findings.
72
   
Digestion of conjugated ubiquitin by trypsin occurs rapidly at its Arg74 
residue, leaving two glycine residues attached to the substrate lysine by an isopeptide 
bond and adding a mass tag of 114.04 Da to the modified tryptic peptide.
37,39,73,74
  
This allows a searchable modification in bottom-up proteomic workflows, making 
trypsin digestion an effective approach for exploring ubiquitinated proteins, as 
outlined in Figure 3.1.  It has been established in the literature that trypsin cleaves 
both unmodified and modified lysine residues in the substrate, the later producing a 
peptide with a terminal lysine modified with the GG tag.
26,28,32,71,73,75
  Cleavage at 




tryptic peptides from an MCF7 lysate and Huebner et al. on 20% of the GG-peptides 
they identified in human urinary exosomes.
28,73
  Burke et al. reported in a study of 
MDSC exosome lysate that 15 of 66 GG-modified tryptic peptides were identified 
with the terminal lysine of the peptide holding the modification.
26
  A subsequent 
paper investigating this phenomenon with K48-linked diubiquitin confirmed that 
trypsin cleaves at the modified K48 about 16% of the time.
75
  Crystal structures show 
that the binding pocket of trypsin is 10-12 Å deep
76,77
 and the extended lysine chain 
with a GG-modification measures 10.9 Å and carries the requisite terminal basic 
residue.
75
  Such studies bring to light the importance of considering peptide 




Figure 3.1. A bottom-up proteomic workflow for ubiquitinated proteins utilizing 
digestion by trypsin and LC-MS/MS with activation by CID. (Adapted from 





Alkylation of cysteine residues after reduction and before digestion during 
bottom-up workflows is an important consideration when exploring ubiquitination as 
a PTM.  Iodoacetamide (IAA) is a commonly used alkylating agent, adding a 
carbamidomethyl group, +57.0513 Da to cysteine residues.  However, overalkylation 
has been reported, with IAA adding two carbamidomethyl groups to lysine residues. 
7,8
  The added mass is +114.04292 Da, exactly that of an added GG-tag, leading to 
possible false identifications.  Chloroacetamide (ClAA) is an alternative alkylating 
agent as it does not overalkylate to the extent of IAA, but the same mass tag is still 
added and the problem could still arise.
7
  To avoid this issue, methyl 
methanethiosulfonate (MMTS) has been used here, which does not readily alkylate 
lysine and adds a mass tag of +45.988 on cysteine residues to allow for no mass tag 
ambiguity. 
 
3.2 Materials and methods 
3.2.1 Materials 
 All materials and chemicals were purchased from Sigma Aldrich (St. Louis, 
MI) unless otherwise stated. 
3.2.2 Biological sample preparation and protein analysis 
MDSC-derived exosomes were isolated and purified by methods previously 
described.
26
  Exosomes were stored at -80 °C until use.  All procedures with animals 
and animal-derived materials were approved by the UMBC and UMCP Institutional 




trypsin, as previously described in Chapter 2, using MMTS as the alkylating agent.  
After LC-MS/MS analysis of three technical replicates for each of three biological 
replicates, spectra were searched with the fixed and variable modifications previously 
described in Chapter 2 and Figure 2.1, including the variable lysine modification of 
glycinylglycine to identify ubiquitinated peptides and proteins using PepArML. 
Subcellular location and function assignments of the identified proteins were made 
using the Protein Information Resource GO Slim (http://pir.georgetown.edu) using 
UniProt Gene Ontology annotations (05 2016).  Hydrophobicity and chemical 
characteristic analyses were performed by ExPASy Bioinformatics Resource Portal 
ProtParam.
51
  A summary of this bottom-up workflow is provided in Figure 2.1. 
3.2.3 Immunoprecipitations 
 All IP experiments used protein A-functionalized sepharose beads added to 
snap cap spin columns and prepared by washing with PBS for 1 hour at 4 °C followed 
by additional washes of 0.1% BSA in PBS.  Two IP procedures were evaluated to 
analyze the ubiquitinated proteins in the MDSC exosome lysate.  In the first, the anti-
ubiquitin antibody #3933S (Cell Signaling, 1:20) was incubated with the prepared 
beads for 4 hours at 4 °C followed by chemical crosslinking using DSS and 
incubation of 100 ug of exosome lysate with the antibody crosslinked beads overnight 
at 4 °C.  In the second, the anti-ubiquitin antibody #19271 (Abcam, 5 ug) was 
incubated directly with 100 ug of exosome lysate for 1 hour at 4 °C followed by a 1 
hour incubation with the prepared protein A-sepharose beads at 4 °C.  For both 
antibodies, centrifugation at 1000 g for 5 minutes was performed directly after lysate 




performed twice with the addition of 0.2 M glycine solution (pH=2.6) incubated for 1 
hour at 4 °C, collection by centrifugation at 13000 g for 5 minutes, and supernatant 
neutralization with 1 M Tris-base (pH=8.5).  The eluate was buffer exchanged to 50 
mM ammonium bicarbonate before further analysis.   
3.2.4 Western blotting 
Western blotting was performed by 1D SDS-Page with transfer onto PVDF 
membrane at 250 mA and 100 V for 50 minutes.  Blocking was performed for 2 hours 
at 4 °C in 5% BSA TBS/T buffer.  The primary antibody used was Cell Signaling 
rabbit anti-ubiquitin antibody #3933S, diluted 1:1000, and incubated at 4 °C for 14 
hours.  The secondary antibody used was Cell Signaling anti-mouse IgG HRP-linked 
antibody #7076, diluted 1:2000, and incubated at 4 °C for 2 hours.  Imagining was 
performed using Super Signal West Dura Substrate Kit and a ChemiDoc Imager (Bio-
Rad, Hercules, CA). 
 
3.3 Results and discussion 
3.3.1 Confirmation of ubiquitinated proteins by immunoprecipitation 
 It has previously been reported that MDSC exosomes contain ubiquitinated 
proteins.
26
  This was confirmed by western blotting the exosome lysate for ubiquitin, 
shown in Figure 3.2a.  Immunoprecipitation by two anti-ubiquitin antibodies was 
evaluated by western blotting to further confirm and visualize the presence of 
ubiquitinated proteins in the exosome lysate.  Anti-ubiquitin antibody #3933 clearly 




non-bound fraction (Figure 3.2c).  Anti-ubiquitin antibody #19271 showed more 
efficient pull down of the higher MW ubiquitin band than the lower MW band, as 
seen in Figure 3.2e.  Antibody bleeding during immunoprecipitation elution and 
subsequent western blot probing is an important consideration, as an eluted antibody 
would give false positive signals at 25 and 50 kDa for the light and heavy chains of 
the antibody.  Negative controls were performed for each IP experiment of only 
antibody addition (#3933 and #19271 respectively) without any lysate protein 
addition.  Blots are shown in Figures 3.2d and 3.2f respectively. Any antibody elution 
during the IP experiments is under the limit of detection by this western blot protocol.   
 
 
Figure 3.2a-f. Western blots probing with anti-ubiquitin antibody #3933 of (a) 
exosome lysate, (b) eluate of #3933 immunoprecipitation, (c) non-bound fraction 
from #3933 immunoprecipitation, (d) negative control of #3933 immunoprecipitation, 





 These three independent western blots for ubiquitin show discrete bands of 
ubiquitinated proteins.  Similar discrete bands were also seen by Liu et al. and 
Buschow et al., who hypothesized that these discrete bands were caused by 
dominantly monoubiquitinated proteins.
21,78
  These results are consistent with the 
conclusion of Gilda et al. that there are differences in the affinities of anti-ubiquitin 
antibodies
72
 and limits in their use for immunoprecipitation.  
3.3.2 Bottom-up identification of ubiquitinated proteins 
In order to carry out an unbiased study of the MDSC exosome ubiquitome, 
bottom-up proteomic strategies were employed directly on the lysate, without prior 
antibody enrichment.  Utilizing tryptic digestion and the GG-tag variable 
modification in bioinformatic searches, 304 ubiquitinated proteins were identified in 
the MDSC exosomes based on 424 GG-peptides.  A table of all the ubiquitinated 
proteins identified with the GG-modified peptide sequences is provided in Appendix 
Table 2.  This indicates that a third of the protein cargo in these exosomes is 
ubiquitinated.  A recent study looking for ubiquitinated proteins in human urinary 
exosomes also reported a high abundance, 13%, of ubiquitinated proteins.
28
  Fifty 
percent of the GG sites identified experimentally are predicted as ubiquitination sites 
in silico by the ubiquitination prediction tool UbiProber
79
 with probabilities greater 
than UbiProber’s confidence level of 0.7.  Based on the 424 ubiquitinated peptides 
and 489 GG-sites identified, 126 proteins were identified with multiple sites of 
ubiquitination.  This multi-ubiquitinated protein cohort was also compared to the total 




Unspecified polyubiquitins were identified based on three peptides that have a 
GG-modified lysine.  The identified peptides indicate that polyubiquitins exist in the 
exosome lysate with branched points at K11, K48, and K63.  The length and topology 
of the polyubiquitin chains, anchored or unanchored, cannot be identified from the 
peptides.  Nine of the 30 identified 26S proteasome components were identified as 
ubiquitinated.  One of these subunits, 26S proteasome regulatory subunit 4, has also 
been reported as ubiquitinated in urinary exosomes.
28
  Seven of these ubiquitinated 
proteasome components are also identified as unconjugated at the same sites, 
including 26S proteasome regulatory subunit 4.   
Chemical analyses including GRAVY scores (Figure 3.3a), isoelectric point 
(Figure 3.3b), and molecular weight distributions (Figure 3.4a-b) were carried out on 
the ubiquitinated and multi-ubiquitinated cohort and compared to those profiled for 
the whole exosome lysate.  Three of the four largest proteins identified in the 
exosome lysate have multiple sites of ubiquitination; nesprin-1, E3 ubiquitin-protein 





Figure 3.3a-b. The distribution of the (a) grand average for hydropathy, GRAVY, scores and 
the (b) isoelectric points, pI, of proteins identified in the exosome lysate, ubiquitinated 
cohort, and multi-ubiquitinated protein cohort.  The bolded line is the data set median, the 
upper box is the top quartile, the whisker above it represents the maximum value, the lower 
box represents the lower quartile, the lower whisker represents the minimum value, and all 





Figure 3.4a-b. MW distributions of substrate proteins in the (a) ubiquitinated cohort 
and (b) multi-ubiquitinated protein cohort. 
 
Biological characteristics of three protein cohorts were compared; proteins 
identified as multi-ubiquitinated, all proteins identified as ubiquitinated (including 




proteome (including all proteins also identified as ubiquitinated).  As shown in Figure 
3.5a, the proteins conjugated by ubiquitin, orange bars, are enriched in nucleoside and 
nucleotide binding functions compared to the entire lysate, and comparable 
enrichment can be seen in these two nucleic acid-related categories in the multi-
ubiquitinated protein subset, green bars.  Eleven of 17 histones, 4 of 20 ribosomal 
proteins, and 4 of 11 transcription factors were found to be ubiquitinated which 
contribute to these categories.  In Figure 3.5b, it can be seen that ubiquitinated 
proteins are more likely to originate from the membrane and cytoskeleton of the 
parent cell, consistent with the proven role of ubiquitination in invagination
20
 and also 





Figure 3.5a-b. Comparisons of GO annotations for the parent cells of (a) molecular 
functions and (b) intracellular protein locations of conjugated proteins in the multi-
ubiquitinated protein cohort (green), all conjugated proteins in the ubiquitinated 
cohort (orange), and all proteins in the exosome lysate (blue). Proteins in the multi-
ubiquitinated cohort are included in the total ubiquitinated cohort, and proteins 
identified in the total ubiquitinated cohort are included in the exosome lysate cohort.  




 Three hundred seventeen of the 424 ubiquitinated tryptic peptides 
characterized carry the glycinylglycine modification on the lysine at the carboxyl 
terminal.  These peptide identifications were manually confirmed, and an example of 
an annotated spectrum of a GG-modified tryptic peptide from myosin-9 is shown in 
Figure 3.6.   
 
 
Figure 3.6. Manually annotated spectrum of a terminal K-GG peptide (residue 494-
517) of myosin-9. 
 
3.4 Conclusions 
This study reports 304 ubiquitinated proteins identified in MDSC-derived 
exosomes.  Ubiquitinated proteins must be high in abundance in MDSC exosomes, as 
they were identified and characterized without prior antibody enrichment.  Taking 






total of 343 ubiquitinated proteins have been identified in MDSC exosomes, 
indicating that over 33% of the total exosome lysate is ubiquitinated.  This fraction 
may be higher as there may be GG-peptides not selected during mass spectral 
analysis.  This method utilized the superior sensitivity of state of the art mass 
spectrometry for this in depth analysis.  These findings further support previous 
conclusions
26,28,73,75
 that peptide identifications with modified terminal lysine(s) need 
to be included in lysine PTM analyses.  Transwell migration assays (private 
communication from Professor Suzanne Ostrand-Rosenberg) have shown that some 
component(s) of the MDSC exosome ubiquitome are chemotactic. 
Chemical characteristics of the proteins conjugated by ubiquitin were found to 
be similar to those of all the proteins in the exosome lysate.  However, proteins that 
bind nucleosides and nucleotides in the parent cell appear to be favored for 
ubiquitination as exosome cargo.  For example, 11 of 17 histones are identified as 
ubiquitinated, along with 4 ribosomal proteins and 4 transcription factors. 
Although there is evidence for K-11, K-48, and K-63 polyubiquitins in the 
exosome lysate, top-down studies on intact proteins are needed to characterize the 
extent and nature of ubiquitination.  One hundred twenty-six proteins were identified 
as multi-ubiquitinated.  Top-down experiments could investigate whether multi-
ubiquitination happens on the same proteoform.   
 Currently it is assumed that selective sorting takes place in proteins that end 
up in multivesicular bodies that are released as exosomes.  The mechanism for such 
protein sorting into exosomes is highly contested.  As was discussed in Chapter 1, 




MVBs destined to be released as exosomes: that deubiquitination must occur during 
MVB sorting,
33,41
 and the contrary view that the ubiquitination tag is needed for 
protein sorting into MVBs.
21,28
  The observations reported in Chapter 3 that a large 
and diverse fraction of the exosome protein cargo is ubiquitinated in MDSC 
exosomes appears to argue against the hypothesis that deubiquitination is necessary 
for proteins to be sorted into MVBs destined to be released as exosomes.  However, 
the results present in Chapter 2 identified a full set of the enzymes required for 
ubiquitination and deubiquitination.  This raises the possibility that conjugation of 



















A0A087WQS2 Basic leucine zipper and W2 domain-containing 
protein 1  
2 11.8% 
A0A087WR50 Fibronectin  71 56.4% 
A0A087WRZ5 TAR DNA-binding protein 43  3 20.4% 
A0A0A0MQ90 Protein S100-A13  2 14.4% 
A0A0A0MQG2 Spectrin beta chain, non-erythrocytic 1 
(Fragment)  
25 19.6% 
A0JNY3 Gephyrin  3 9.6% 
A2A4J1 Proteasome activator complex subunit 3 
(Fragment)  
2 11.8% 
A2A513 Keratin, type I cytoskeletal 10  5 27.3% 
A2A841 Protein 4.1  2 3.9% 
A2ACG7 Dolichyl-diphosphooligosaccharide--protein 
glycosyltransferase subunit 2  
7 24.9% 
A2AD84 Serine/threonine-protein kinase 26  2 7.9% 
A2AE27 AMP deaminase 2  7 12.0% 
A2AFF6 Cohesin subunit SA-2  2 2.8% 
A2AFQ2 3-hydroxyacyl-CoA dehydrogenase type-2  5 39.5% 
A2AH85 116 kDa U5 small nuclear ribonucleoprotein 
component  
19 31.8% 
A2AN08 E3 ubiquitin-protein ligase UBR4  2 0.8% 
A2AP78 High mobility group protein B3 (Fragment)  3 24.5% 
A2AQ07 Tubulin beta-1 chain  13 44.4% 
A2ATU9 Histone acetyltransferase type B catalytic 
subunit  
2 7.3% 
A2AUR7 Ras suppressor protein 1  3 26.2% 
A2AWT7 Nucleolar transcription factor 1  2 4.0% 
A2BDW0 Tyrosine-protein kinase BTK  3 8.9% 
A2CES4 U2 small nuclear ribonucleoprotein B'' 
(Fragment)  
2 18.9% 
A2RTH5 Leucine carboxyl methyltransferase 1  2 9.0% 
A6PWC3 Nardilysin  8 12.4% 
B1AR28 Very long-chain-specific acyl-CoA 
dehydrogenase, mitochondrial  
3 8.8% 




B1ATY1 Actin, cytoplasmic 2  11 84.3% 
B1AUY2 Protein Arhgap4  5 9.6% 
B2M1R6 Heterogeneous nuclear ribonucleoprotein K  8 27.1% 
B2RV77 MCG130182, isoform CRA_a  4 53.6% 
B2RXR6 Serine/threonine-protein phosphatase 6 
regulatory ankyrin repeat subunit B  
3 4.4% 
B5THE2 Maltase-glucoamylase  10 7.8% 
B7FAU9 Filamin, alpha  81 51.5% 
B7ZCL7 H/ACA ribonucleoprotein complex subunit 4 
(Fragment)  
2 13.1% 
B9EJ54 MCG21756, isoform CRA_b  4 3.0% 
D3YUQ9 Elongation factor 1-delta (Fragment)  4 31.4% 
D3YW48 Calpain small subunit 1 (Fragment)  9 78.4% 
D3YWF6 Ubiquitin thioesterase OTUB1  4 30.7% 
D3YX27 Serine protease HTRA2, mitochondrial  2 10.3% 
D3YYD0 Olfactomedin-4  10 24.2% 
D3YYD5 Vacuolar protein sorting-associated protein 29 
(Fragment)  
2 26.6% 
D3YYM6 40S ribosomal protein S5 (Fragment)  2 15.4% 
D3Z315 Coatomer subunit epsilon (Fragment)  3 26.4% 
D3Z5M4 Ankyrin-1  14 12.6% 
D3Z627 Integrin alpha-L  9 13.7% 
D3Z629 60S ribosomal protein L9  2 19.9% 
D3Z6Q9 Bridging integrator 2  5 17.2% 
D3Z712 40S ribosomal protein S15a (Fragment)  2 31.9% 
D3Z7R7 Minor histocompatibility protein HA-1  7 11.8% 
D4AFX7 Protein Dnajc13  5 4.6% 
E0CXA0 Hepatoma-derived growth factor (Fragment)  1 8.4% 
E9PUE7 Active breakpoint cluster region-related protein  4 9.2% 
E9PUF7 Rho guanine nucleotide exchange factor 1  9 15.6% 
E9PV24 Fibrinogen alpha chain  13 29.4% 
E9PV60 Protein Wdfy4  2 1.2% 
E9PVA8 Protein Gcn1l1  3 2.2% 
E9PW39 Putative helicase MOV-10  3 5.0% 
E9PWG6 Protein Ncapg  2 3.0% 
E9PWY9 Phenylalanine--tRNA ligase alpha subunit  3 9.5% 
E9PYD5 Transcription elongation factor A protein 1  2 13.1% 
E9PYM7 Alpha-mannosidase (Fragment)  2 2.8% 
E9PYV4 Protein Niban  7 24.7% 
E9PZF0 Nucleoside diphosphate kinase  9 48.3% 
E9Q070 Uncharacterized protein  6 32.8% 




triphosphohydrolase SAMHD1  
E9Q1N8 Uncharacterized protein  2 9.6% 
E9Q1S3 Protein transport protein Sec23A  5 13.2% 
E9Q397 Spectrin beta chain, erythrocytic  48 33.8% 
E9Q3X0 Major vault protein  30 57.9% 
E9Q450 Tropomyosin alpha-1 chain  7 31.7% 
E9Q604 Integrin alpha-M  31 46.9% 
E9Q800 MICOS complex subunit Mic60  2 5.7% 
E9Q8H9 Complement factor H  2 3.1% 
E9QAI5 CAD protein  5 3.7% 
E9QKR0 Guanine nucleotide-binding protein 
G(I)/G(S)/G(T) subunit beta-2  
4 16.8% 
E9QKT1 Ubiquitin-protein ligase E3A  2 3.8% 
E9QKZ2 Importin-9  6 13.8% 
E9QNN1 ATP-dependent RNA helicase A  15 20.5% 
F6QA74 DNA-(apurinic or apyrimidinic site) lyase 
(Fragment)  
5 36.3% 
F6RPJ9 Insulin-degrading enzyme (Fragment)  2 2.6% 
F6RQA2 Ribosomal protein S6 kinase  4 7.7% 
F6UND7 Tyrosine-protein kinase HCK  5 16.6% 
F6W687 Non-histone chromosomal protein HMG-17 
(Fragment)  
3 41.1% 
F6YVP7 Uncharacterized protein  4 24.3% 
F6YY69 14-3-3 protein theta (Fragment)  9 40.4% 
F7CHQ7 Nucleolar protein 56 (Fragment)  2 12.6% 
F8VPN4 Protein Agl  2 2.3% 
F8VPX1 Ubiquitin carboxyl-terminal hydrolase  12 17.4% 
F8WGL3 Cofilin-1  6 42.3% 
F8WGM5 Syntaxin-binding protein 2 (Fragment)  5 15.5% 
F8WHL2 Coatomer subunit alpha  8 10.7% 
F8WHZ9 Alpha-adducin  3 6.2% 
F8WI35 Histone H3  5 60.0% 
G3UVV6 MCG123217  3 3.8% 
G3UXZ5 Proteasome activator complex subunit 1 
(Fragment)  
3 18.9% 
G3UY93 Valine--tRNA ligase (Fragment)  12 18.6% 
G3UYY1 Serine hydroxymethyltransferase (Fragment)  3 10.7% 
G3UZG5 Kelch domain-containing protein 4  2 7.6% 
G3X8U3 MCG6895  2 10.4% 
G3X8Y3 N-alpha-acetyltransferase 15, NatA auxiliary 
subunit  
3 7.4% 




G3X956 FACT complex subunit SPT16  2 4.1% 
G3X972 Protein Sec24c  5 9.1% 
G3X9G4 Dynamin-2  13 30.0% 
G3X9I4 Aly/REF export factor 2  3 25.7% 
G3X9T8 Ceruloplasmin  9 15.1% 
G5E866 Splicing factor 3B subunit 1  13 18.6% 
G5E8N5 L-lactate dehydrogenase  13 60.4% 
G5E924 Heterogeneous nuclear ribonucleoprotein L 
(Fragment)  
9 33.2% 
H3BKH6 S-formylglutathione hydrolase  5 39.0% 
H3BKN2 Alkyldihydroxyacetonephosphate synthase, 
peroxisomal  
2 6.0% 
H3BLE7 Serine/threonine-protein phosphatase 2A 65 kDa 
regulatory subunit A beta isoform  
4 11.9% 
I7HPV9 Phosphatidylinositol 3,4,5-trisphosphate-
dependent Rac exchanger 1 protein  
2 2.8% 
J3QMV5 Cytokine receptor-like factor 3  2 21.4% 
J3QPG5 Prosaposin  2 4.7% 
K3W4L0 Unconventional myosin-XVIIIa  3 3.1% 
K3W4R2 Myosin-14  6 4.1% 
O08553 Dihydropyrimidinase-related protein 2  5 19.6% 
O08582 GTP-binding protein 1  3 8.1% 
O08663 Methionine aminopeptidase 2  2 8.0% 
O08692 Myeloid bactenecin (F1)  10 71.9% 
O08709 Peroxiredoxin-6  9 64.7% 
O08738 Caspase-6  3 13.4% 
O08739 AMP deaminase 3  11 26.4% 
O08749 Dihydrolipoyl dehydrogenase, mitochondrial  6 24.0% 
O08795 Glucosidase 2 subunit beta  2 4.2% 
O08992 Syntenin-1  7 58.5% 
O09061 Proteasome subunit beta type-1  9 58.8% 
O09106 Histone deacetylase 1  8 25.3% 
O09159 Lysosomal alpha-mannosidase  14 25.7% 
O09172 Glutamate--cysteine ligase regulatory subunit  2 11.3% 
O35129 Prohibitin-2  2 10.4% 
O35286 Putative pre-mRNA-splicing factor ATP-
dependent RNA helicase DHX15  
8 14.5% 
O35295 Transcriptional activator protein Pur-beta  3 25.3% 
O35343 Importin subunit alpha-3  4 15.6% 
O35350 Calpain-1 catalytic subunit  14 24.3% 






O35639 Annexin A3  15 63.2% 
O35643 AP-1 complex subunit beta-1  16 31.7% 
O35737 Heterogeneous nuclear ribonucleoprotein H  4 13.4% 
O35744 Chitinase-like protein 3  15 60.1% 
O35841 Apoptosis inhibitor 5  5 16.9% 
O35864 COP9 signalosome complex subunit 5  3 13.8% 
O35930 Platelet glycoprotein Ib alpha chain  4 10.6% 
O35955 Proteasome subunit beta type-10  2 14.7% 
O54774 AP-3 complex subunit delta-1  2 2.8% 
O54824 Pro-interleukin-16  3 4.0% 
O54890 Integrin beta-3  3 6.1% 
O54962 Barrier-to-autointegration factor  2 42.7% 
O55013 Trafficking protein particle complex subunit 3  2 15.0% 
O55029 Coatomer subunit beta'  8 14.1% 
O55098 Serine/threonine-protein kinase 10  2 4.1% 
O55131 Septin-7  3 13.1% 
O55222 Integrin-linked protein kinase  8 25.0% 
O55234 Proteasome subunit beta type-5  7 40.9% 
O70138 Neutrophil collagenase  14 38.1% 
O70145 Neutrophil cytosol factor 2  12 35.4% 
O70194 Eukaryotic translation initiation factor 3 subunit 
D  
9 27.6% 
O70251 Elongation factor 1-beta  3 26.7% 
O70310 Glycylpeptide N-tetradecanoyltransferase 1  4 15.9% 
O70325 Phospholipid hydroperoxide glutathione 
peroxidase, mitochondrial  
2 13.2% 
O70435 Proteasome subunit alpha type-3  5 23.1% 
O70497 Ficolin-2  2 15.6% 
O70591 Prefoldin subunit 2  2 16.9% 
O88307 Sortilin-related receptor  17 11.3% 
O88342 WD repeat-containing protein 1  18 56.3% 
O88456 Calpain small subunit 1  9 70.6% 
O88487 Cytoplasmic dynein 1 intermediate chain 2  3 10.6% 
O88543 COP9 signalosome complex subunit 3  2 7.3% 
O88544 COP9 signalosome complex subunit 4  8 31.3% 
O88545 COP9 signalosome complex subunit 6  3 21.6% 
O88569 Heterogeneous nuclear ribonucleoproteins 
A2/B1  
12 43.3% 
O88593 Peptidoglycan recognition protein 1  5 50.0% 
O88685 26S protease regulatory subunit 6A  10 40.1% 






O88783 Coagulation factor V  3 1.9% 
O88842 FYVE, RhoGEF and PH domain-containing 
protein 3  
2 5.5% 
O88844 Isocitrate dehydrogenase [NADP] cytoplasmic  15 50.2% 
O88879 Apoptotic protease-activating factor 1  2 2.3% 
O88958 Glucosamine-6-phosphate isomerase 1  2 8.3% 
O88968 Transcobalamin-2  4 19.5% 
O89051 Integral membrane protein 2B  2 8.7% 
O89053 Coronin-1A  15 52.7% 




P00920 Carbonic anhydrase 2  4 30.0% 
P01027 Complement C3  70 61.6% 
P01325 Insulin-1  2 18.5% 
P01837 Ig kappa chain C region  2 50.0% 
P01872 Ig mu chain C region  12 39.4% 
P01900 H-2 class I histocompatibility antigen, D-D 
alpha chain  
2 6.9% 
P01942 Hemoglobin subunit alpha  7 83.8% 
P02088 Hemoglobin subunit beta-1  11 95.2% 
P02089 Hemoglobin subunit beta-2  11 91.2% 
P02301 Histone H3.3C  6 60.3% 
P02535 Keratin, type I cytoskeletal 10  5 26.7% 
P03958 Adenosine deaminase  2 8.5% 
P04104 Keratin, type II cytoskeletal 1  3 13.0% 
P04202 Transforming growth factor beta-1  2 8.2% 
P04919 Band 3 anion transport protein  13 27.1% 
P05064 Fructose-bisphosphate aldolase A  16 77.2% 
P05201 Aspartate aminotransferase, cytoplasmic  5 23.2% 
P05202 Aspartate aminotransferase, mitochondrial  7 30.0% 
P06745 Glucose-6-phosphate isomerase  22 69.7% 
P07356 Annexin A2  14 59.9% 
P07724 Serum albumin  18 40.6% 
P07742 Ribonucleoside-diphosphate reductase large 
subunit  
8 20.0% 
P07759 Serine protease inhibitor A3K  4 17.7% 
P07901 Heat shock protein HSP 90-alpha  24 48.3% 
P08003 Protein disulfide-isomerase A4  13 33.4% 
P08030 Adenine phosphoribosyltransferase  7 61.1% 
P08032 Spectrin alpha chain, erythrocytic 1  73 47.7% 




P08113 Endoplasmin  9 18.2% 
P08226 Apolipoprotein E  6 38.3% 
P08228 Superoxide dismutase [Cu-Zn]  4 32.5% 
P08249 Malate dehydrogenase, mitochondrial  8 35.8% 
P08607 C4b-binding protein  5 13.2% 
P08752 Guanine nucleotide-binding protein G(i) subunit 
alpha-2  
9 35.5% 
P08905 Lysozyme C-2  3 33.1% 
P09103 Protein disulfide-isomerase  18 51.3% 
P09405 Nucleolin  11 21.4% 
P09411 Phosphoglycerate kinase 1  14 53.5% 
P09528 Ferritin heavy chain  8 68.7% 
P09542 Myosin light chain 3  2 12.3% 
P09671 Superoxide dismutase [Mn], mitochondrial  2 12.6% 
P0C0S6 Histone H2A.Z  5 58.6% 
P0CG50 Polyubiquitin-C  6 9.8% 
P10107 Annexin A1  16 64.5% 
P10126 Elongation factor 1-alpha 1  13 48.1% 
P10518 Delta-aminolevulinic acid dehydratase  6 38.5% 
P10639 Thioredoxin  3 31.4% 
P10649 Glutathione S-transferase Mu 1  7 42.2% 
P10810 Monocyte differentiation antigen CD14  3 13.4% 
P10852 4F2 cell-surface antigen heavy chain  3 12.7% 
P11031 Activated RNA polymerase II transcriptional 
coactivator p15  
4 37.8% 
P11247 Myeloperoxidase  27 50.4% 
P11352 Glutathione peroxidase 1  7 49.3% 
P11499 Heat shock protein HSP 90-beta  23 50.4% 
P11672 Neutrophil gelatinase-associated lipocalin  6 51.0% 
P11835 Integrin beta-2  16 33.6% 
P11983 T-complex protein 1 subunit alpha  12 39.6% 
P12246 Serum amyloid P-component  2 14.3% 
P12265 Beta-glucuronidase  7 19.1% 
P12382 ATP-dependent 6-phosphofructokinase, liver 
type  
3 6.3% 
P12787 Cytochrome c oxidase subunit 5A, mitochondrial  4 51.4% 
P12815 Programmed cell death protein 6  6 52.4% 
P13020 Gelsolin  19 48.0% 
P13439 Uridine 5'-monophosphate synthase  2 6.4% 
P13864 DNA (cytosine-5)-methyltransferase 1  3 3.8% 
P14069 Protein S100-A6  6 80.9% 




P14152 Malate dehydrogenase, cytoplasmic  6 26.4% 
P14206 40S ribosomal protein SA  10 52.2% 
P14211 Calreticulin  9 46.2% 
P14234 Tyrosine-protein kinase Fgr  5 18.0% 
P14685 26S proteasome non-ATPase regulatory subunit 
3  
11 36.2% 
P14733 Lamin-B1  9 25.5% 
P14824 Annexin A6  10 22.3% 
P15532 Nucleoside diphosphate kinase A  7 65.8% 
P15864 Histone H1.2  6 37.7% 
P16110 Galectin-3  7 40.9% 
P16125 L-lactate dehydrogenase B chain  3 12.9% 
P16546 Spectrin alpha chain, non-erythrocytic 1  48 34.4% 
P16858 Glyceraldehyde-3-phosphate dehydrogenase  13 67.0% 
P16879 Tyrosine-protein kinase Fes/Fps  3 6.1% 
P17095 High mobility group protein HMG-I/HMG-Y  1 23.4% 
P17182 Alpha-enolase  19 70.1% 
P17225 Polypyrimidine tract-binding protein 1  9 33.0% 
P17426 AP-2 complex subunit alpha-1  9 15.2% 
P17427 AP-2 complex subunit alpha-2  16 30.1% 
P17433 Transcription factor PU.1  2 8.5% 
P17710 Hexokinase-1  6 9.5% 
P17742 Peptidyl-prolyl cis-trans isomerase A  8 70.7% 
P17751 Triosephosphate isomerase  9 48.2% 
P17879 Heat shock 70 kDa protein 1B  5 15.0% 
P18242 Cathepsin D  5 23.2% 
P19096 Fatty acid synthase  30 21.2% 
P19157 Glutathione S-transferase P 1  3 20.5% 
P19973 Lymphocyte-specific protein 1  6 34.9% 
P20029 78 kDa glucose-regulated protein  21 49.6% 
P20060 Beta-hexosaminidase subunit beta  5 17.7% 
P20152 Vimentin  19 51.3% 
P21107-2 Isoform 2 of Tropomyosin alpha-3 chain  8 41.1% 
P21550 Beta-enolase  9 29.3% 
P22682 E3 ubiquitin-protein ligase CBL  2 3.0% 
P22892 AP-1 complex subunit gamma-1  10 20.2% 
P23116 Eukaryotic translation initiation factor 3 subunit 
A  
12 14.7% 
P24270 Catalase  14 40.8% 
P24369 Peptidyl-prolyl cis-trans isomerase B  7 38.9% 
P24527 Leukotriene A-4 hydrolase  13 33.1% 




P25206 DNA replication licensing factor MCM3  5 12.4% 
P25911-2 Isoform 2 of Tyrosine-protein kinase Lyn  13 44.4% 
P26039 Talin-1  72 50.3% 
P26040 Ezrin  14 31.1% 
P26041 Moesin  26 60.0% 
P26043 Radixin  16 37.7% 
P26369 Splicing factor U2AF 65 kDa subunit  6 25.1% 
P26443 Glutamate dehydrogenase 1, mitochondrial  16 45.7% 
P26516 26S proteasome non-ATPase regulatory subunit 
7  
8 53.0% 
P26638 Serine--tRNA ligase, cytoplasmic  3 10.7% 
P27005 Protein S100-A8  5 94.4% 
P27048 Small nuclear ribonucleoprotein-associated 
protein B  
2 12.6% 
P27612 Phospholipase A-2-activating protein  6 13.7% 
P27661 Histone H2AX  6 60.8% 
P27773 Protein disulfide-isomerase A3  21 57.2% 
P27870 Proto-oncogene vav  10 17.6% 
P28063 Proteasome subunit beta type-8  8 40.9% 
P28076 Proteasome subunit beta type-9  4 24.7% 
P28293 Cathepsin G  9 50.2% 
P28650 Adenylosuccinate synthetase isozyme 1  9 31.3% 
P28656 Nucleosome assembly protein 1-like 1  4 14.6% 
P28658 Ataxin-10  2 4.4% 
P28665 Murinoglobulin-1  5 6.8% 
P28867 Protein kinase C delta type  4 12.3% 
P29341 Polyadenylate-binding protein 1  11 23.4% 
P29351 Tyrosine-protein phosphatase non-receptor type 
6  
17 44.0% 
P29391 Ferritin light chain 1  7 53.0% 
P29416 Beta-hexosaminidase subunit alpha  4 11.4% 
P29699 Alpha-2-HS-glycoprotein  2 15.4% 
P29758 Ornithine aminotransferase, mitochondrial  4 24.2% 
P30416 Peptidyl-prolyl cis-trans isomerase FKBP4  4 14.0% 
P30681 High mobility group protein B2  6 37.1% 
P31725 Protein S100-A9  8 83.2% 
P31938 Dual specificity mitogen-activated protein kinase 
kinase 1  
3 16.3% 
P32067 Lupus La protein homolog  4 12.8% 
P32921 Tryptophan--tRNA ligase, cytoplasmic  2 6.9% 
P34884 Macrophage migration inhibitory factor  3 35.7% 




P35505 Fumarylacetoacetase  7 31.0% 
P35564 Calnexin  4 9.0% 
P35585 AP-1 complex subunit mu-1  6 21.8% 
P35700 Peroxiredoxin-1  6 32.2% 
P35821 Tyrosine-protein phosphatase non-receptor type 
1  
2 5.6% 
P35980 60S ribosomal protein L18  3 19.7% 
P38060 Hydroxymethylglutaryl-CoA lyase, 
mitochondrial  
4 24.0% 
P38647 Stress-70 protein, mitochondrial  5 10.5% 
P39655 Arachidonate 12-lipoxygenase, 12S-type  5 13.0% 
P40124 Adenylyl cyclase-associated protein 1  16 57.4% 
P40142 Transketolase  27 67.9% 
P40237 CD82 antigen  2 8.7% 
P40336 Vacuolar protein sorting-associated protein 26A  3 12.8% 
P41241 Tyrosine-protein kinase CSK  3 9.8% 
P41245 Matrix metalloproteinase-9  24 54.7% 
P42227 Signal transducer and activator of transcription 3  8 20.9% 
P42669 Transcriptional activator protein Pur-alpha  3 35.2% 
P42932 T-complex protein 1 subunit theta  11 25.9% 
P43274 Histone H1.4  6 33.8% 
P43275 Histone H1.1  4 31.0% 
P43276 Histone H1.5  6 30.9% 
P43277 Histone H1.3  6 33.5% 
P43430 Mast cell protease 8  1 6.1% 
P45376 Aldose reductase  2 13.9% 
P45591 Cofilin-2  2 16.9% 
P45952 Medium-chain specific acyl-CoA 
dehydrogenase, mitochondrial  
2 10.5% 
P46062 Signal-induced proliferation-associated protein 1  2 3.5% 
P46467 Vacuolar protein sorting-associated protein 4B  8 30.9% 
P46471 26S protease regulatory subunit 7  6 22.2% 
P46664 Adenylosuccinate synthetase isozyme 2  3 10.5% 
P47738 Aldehyde dehydrogenase, mitochondrial  21 74.0% 
P47754 F-actin-capping protein subunit alpha-2  7 42.3% 
P47757-2 Isoform 2 of F-actin-capping protein subunit 
beta  
12 67.7% 
P47791 Glutathione reductase, mitochondrial  14 57.6% 
P47809 Dual specificity mitogen-activated protein kinase 
kinase 4  
2 8.6% 
P47811 Mitogen-activated protein kinase 14  6 23.9% 




aminotransferase [isomerizing] 1  
P47911 60S ribosomal protein L6  3 13.9% 
P47941 Crk-like protein  2 13.2% 
P47955 60S acidic ribosomal protein P1  3 72.8% 
P47962 60S ribosomal protein L5  5 21.2% 
P47968 Ribose-5-phosphate isomerase  2 10.9% 
P48025 Tyrosine-protein kinase SYK  18 49.4% 
P48036 Annexin A5  8 37.9% 
P49312 Heterogeneous nuclear ribonucleoprotein A1  8 35.9% 
P49717 DNA replication licensing factor MCM4  3 5.2% 
P49722 Proteasome subunit alpha type-2  8 60.3% 
P49962 Signal recognition particle 9 kDa protein  2 25.6% 
P50247 Adenosylhomocysteinase  8 30.3% 
P50396 Rab GDP dissociation inhibitor alpha  7 30.9% 
P50516 V-type proton ATPase catalytic subunit A  12 39.9% 
P50518 V-type proton ATPase subunit E 1  3 20.8% 
P50543 Protein S100-A11  2 27.6% 
P50580 Proliferation-associated protein 2G4  16 50.3% 
P51125 Calpastatin  3 9.1% 
P51150 Ras-related protein Rab-7a  2 12.1% 
P51174 Long-chain specific acyl-CoA dehydrogenase, 
mitochondrial  
11 34.0% 
P51437 Cathelin-related antimicrobial peptide  2 19.7% 
P51863 V-type proton ATPase subunit d 1  2 11.4% 
P52196 Thiosulfate sulfurtransferase  2 10.4% 
P52480 Pyruvate kinase PKM  23 69.3% 
P52624 Uridine phosphorylase 1  9 56.6% 
P54071 Isocitrate dehydrogenase [NADP], mitochondrial  9 27.0% 
P54775 26S protease regulatory subunit 6B  9 42.3% 
P54822 Adenylosuccinate lyase  2 6.8% 
P54823 Probable ATP-dependent RNA helicase DDX6  11 39.1% 
P54923 Protein ADP-ribosylarginine hydrolase, [Protein 
ADP-ribosylarginine] hydrolase  
2 12.7% 
P54987 Cis-aconitate decarboxylase  2 10.5% 
P55258 Ras-related protein Rab-8A  3 17.9% 
P55264 Adenosine kinase  3 13.0% 
P56399 Ubiquitin carboxyl-terminal hydrolase 5  6 13.4% 
P56480 ATP synthase subunit beta, mitochondrial  15 52.4% 
P57759 Endoplasmic reticulum resident protein 29  3 18.7% 
P57780 Alpha-actinin-4  37 62.2% 
P57784 U2 small nuclear ribonucleoprotein A'  5 38.4% 




P58252 Elongation factor 2  28 51.2% 
P58389 Serine/threonine-protein phosphatase 2A 
activator  
2 12.1% 
P59325 Eukaryotic translation initiation factor 5  2 5.6% 
P59999 Actin-related protein 2/3 complex subunit 4  8 66.1% 
P60122 RuvB-like 1  6 18.9% 
P60229 Eukaryotic translation initiation factor 3 subunit 
E  
13 37.8% 
P60335 Poly(rC)-binding protein 1  5 25.8% 
P60710 Actin, cytoplasmic 1  26 97.1% 
P60766 Cell division control protein 42 homolog  8 68.6% 
P60843 Eukaryotic initiation factor 4A-I  15 55.9% 
P60867 40S ribosomal protein S20  2 19.3% 
P61021 Ras-related protein Rab-5B  3 20.5% 
P61161 Actin-related protein 2  14 48.7% 
P61164 Alpha-centractin  8 39.1% 
P61202 COP9 signalosome complex subunit 2  4 12.2% 
P61222 ATP-binding cassette sub-family E member 1  4 11.2% 
P61759 Prefoldin subunit 3  2 22.5% 
P61967 AP-1 complex subunit sigma-1A  2 15.8% 
P61982 14-3-3 protein gamma  8 50.6% 
P62082 40S ribosomal protein S7  3 33.0% 
P62137 Serine/threonine-protein phosphatase PP1-alpha 
catalytic subunit  
7 29.7% 
P62141 Serine/threonine-protein phosphatase PP1-beta 
catalytic subunit  
6 27.2% 
P62192 26S protease regulatory subunit 4  6 23.0% 
P62242 40S ribosomal protein S8  3 18.8% 
P62259 14-3-3 protein epsilon  10 57.7% 
P62305 Small nuclear ribonucleoprotein E  2 25.0% 
P62307 Small nuclear ribonucleoprotein F  2 55.8% 
P62309 Small nuclear ribonucleoprotein G  2 26.3% 
P62315 Small nuclear ribonucleoprotein Sm D1  4 54.6% 
P62317 Small nuclear ribonucleoprotein Sm D2  5 47.5% 
P62320 Small nuclear ribonucleoprotein Sm D3  3 31.8% 
P62334 26S protease regulatory subunit 10B  6 26.0% 
P62492 Ras-related protein Rab-11A  2 19.4% 
P62702 40S ribosomal protein S4, X isoform  3 15.2% 
P62746 Rho-related GTP-binding protein RhoB  5 48.0% 
P62748 Hippocalcin-like protein 1  3 21.8% 
P62806 Histone H4  5 61.2% 




P62821 Ras-related protein Rab-1A  4 30.7% 
P62827 GTP-binding nuclear protein Ran  8 59.3% 
P62830 60S ribosomal protein L23  2 25.0% 
P62843 40S ribosomal protein S15  2 28.3% 
P62855 40S ribosomal protein S26  2 20.9% 
P62889 60S ribosomal protein L30  2 24.4% 
P62908 40S ribosomal protein S3  4 25.5% 
P62960 Nuclease-sensitive element-binding protein 1  5 31.4% 
P62962 Profilin-1  7 65.0% 
P62996 Transformer-2 protein homolog beta  2 10.4% 
P63001 Ras-related C3 botulinum toxin substrate 1  5 36.5% 
P63005 Platelet-activating factor acetylhydrolase IB 
subunit alpha  
8 28.5% 
P63017 Heat shock cognate 71 kDa protein  30 73.4% 
P63028 Translationally-controlled tumor protein  2 35.5% 
P63085 Mitogen-activated protein kinase 1  7 27.4% 
P63101 14-3-3 protein zeta/delta  11 62.5% 
P63158 High mobility group protein B1  7 40.0% 
P63242 Eukaryotic translation initiation factor 5A-1  6 70.8% 
P63276 40S ribosomal protein S17  2 32.6% 
P63328-2 Serine/threonine-protein phosphatase 2B 
catalytic subunit alpha isoform Isoform 2 of  
4 16.6% 
P63330 Serine/threonine-protein phosphatase 2A 
catalytic subunit alpha isoform  
6 31.7% 
P67778 Prohibitin  4 24.6% 
P67871 Casein kinase II subunit beta  2 15.8% 
P68033 Actin, alpha cardiac muscle 1  18 68.4% 
P68037 Ubiquitin-conjugating enzyme E2 L3  3 40.3% 
P68040 Guanine nucleotide-binding protein subunit beta-
2-like 1  
9 45.7% 
P68368 Tubulin alpha-4A chain  15 59.8% 
P68369 Tubulin alpha-1A chain  15 59.4% 
P68372 Tubulin beta-4B chain  21 69.2% 
P68373 Tubulin alpha-1C chain  15 59.7% 
P68433 Histone H3.1  6 60.3% 
P68510 14-3-3 protein eta  4 27.2% 
P70168 Importin subunit beta-1  21 44.1% 
P70195 Proteasome subunit beta type-7  9 55.2% 
P70268 Serine/threonine-protein kinase N1  2 5.3% 
P70290 55 kDa erythrocyte membrane protein  4 13.7% 
P70296 Phosphatidylethanolamine-binding protein 1  2 20.9% 




P70372 ELAV-like protein 1  3 12.9% 
P70398 Probable ubiquitin carboxyl-terminal hydrolase 
FAF-X  
5 4.1% 
P70404 Isocitrate dehydrogenase [NAD] subunit gamma 
1, mitochondrial  
2 13.7% 
P70441 Na(+)/H(+) exchange regulatory cofactor NHE-
RF1  
2 7.0% 
P70460 Vasodilator-stimulated phosphoprotein  8 31.7% 
P70670 Nascent polypeptide-associated complex subunit 
alpha, muscle-specific form  
3 1.9% 
P70677 Caspase-3  2 11.9% 
P70698 CTP synthase 1  4 11.5% 
P80313 T-complex protein 1 subunit eta  7 23.4% 
P80314 T-complex protein 1 subunit beta  8 29.2% 
P80315 T-complex protein 1 subunit delta  8 25.1% 
P80316 T-complex protein 1 subunit epsilon  6 25.5% 
P80317 T-complex protein 1 subunit zeta  6 21.5% 
P80318 T-complex protein 1 subunit gamma  14 38.4% 
P82198 Transforming growth factor-beta-induced 
protein ig-h3  
21 57.3% 
P84078 ADP-ribosylation factor 1  6 49.7% 
P84084 ADP-ribosylation factor 5  6 55.0% 
P84089 Enhancer of rudimentary homolog  2 40.4% 
P84091 AP-2 complex subunit mu  6 25.1% 
P84096 Rho-related GTP-binding protein RhoG  4 31.4% 
P84228 Histone H3.2  6 61.0% 
P97310 DNA replication licensing factor MCM2  4 8.4% 
P97369 Neutrophil cytosol factor 4  9 45.1% 
P97372 Proteasome activator complex subunit 2  3 20.9% 
P97384 Annexin A11  12 29.8% 
P97450 ATP synthase-coupling factor 6, mitochondrial  2 34.3% 
P97807 Fumarate hydratase, mitochondrial  8 30.6% 
P97814 Proline-serine-threonine phosphatase-interacting 
protein 1  
2 8.0% 
P99024 Tubulin beta-5 chain  21 69.4% 
P99026 Proteasome subunit beta type-4  8 55.7% 
P99027 60S acidic ribosomal protein P2  4 69.6% 
P99029 Peroxiredoxin-5, mitochondrial  7 49.1% 
Q00519 Xanthine dehydrogenase/oxidase  23 33.4% 
Q00612 Glucose-6-phosphate 1-dehydrogenase X  30 74.2% 
Q00PI9 Heterogeneous nuclear ribonucleoprotein U-like 
protein 2  
2 5.4% 




Q01853 Transitional endoplasmic reticulum ATPase  34 70.7% 
Q02053 Ubiquitin-activating enzyme EI (Ubiquitin-like 
modifier-activating enzyme 1) 
32 53.8% 
Q03265 ATP synthase subunit alpha, mitochondrial  8 21.2% 
Q04750 DNA topoisomerase 1  17 27.8% 
Q05144 Ras-related C3 botulinum toxin substrate 2  7 53.1% 
Q06138 Calcium-binding protein 39  2 7.0% 
Q07076 Annexin A7  7 23.3% 
Q07417 Short-chain specific acyl-CoA dehydrogenase, 
mitochondrial  
2 10.4% 
Q07797 Galectin-3-binding protein  3 9.9% 
Q09014 Neutrophil cytosol factor 1  13 50.5% 
Q09PK2 Retroviral-like aspartic protease 1  8 58.1% 
Q11011 Puromycin-sensitive aminopeptidase  23 38.8% 
Q14CH1 Molybdenum cofactor sulfurase  2 5.1% 
Q3THE2 Myosin regulatory light chain 12B  9 79.7% 
Q3THK7 GMP synthase [glutamine-hydrolyzing]  2 5.3% 
Q3TKD0 Transportin-1 (Fragment)  8 15.6% 
Q3TRM8 Hexokinase-3  25 43.1% 
Q3TTY5 Keratin, type II cytoskeletal 2 epidermal  3 9.3% 
Q3TVK3 Aspartyl aminopeptidase  10 34.7% 
Q3TW96 UDP-N-acetylhexosamine pyrophosphorylase-
like protein 1  
4 11.4% 
Q3TXS7 26S proteasome non-ATPase regulatory subunit 
1  
14 29.9% 
Q3U0V1 Far upstream element-binding protein 2  2 3.6% 
Q3U1J4 DNA damage-binding protein 1  7 10.1% 
Q3U2G2 Heat shock 70 kDa protein 4  17 33.1% 
Q3U7R1 Extended synaptotagmin-1  6 10.4% 
Q3U898 Myeloma-overexpressed gene 2 protein homolog  2 71.9% 
Q3UJB0 Protein Sf3b2  3 3.9% 
Q3UKJ7 WD40 repeat-containing protein SMU1  2 4.9% 
Q3UKW2 Calmodulin  6 60.4% 
Q3UM45 Protein phosphatase 1 regulatory subunit 7  2 10.5% 
Q3UMW7 MAP kinase-activated protein kinase 3  2 8.1% 
Q3UND0 Src kinase-associated phosphoprotein 2  6 24.9% 
Q3UP87 Neutrophil elastase  8 40.8% 
Q3UPV6 Voltage-gated potassium channel subunit beta-2  4 23.8% 
Q3UQ44 Ras GTPase-activating-like protein IQGAP2  4 4.6% 
Q3UYV9 Nuclear cap-binding protein subunit 1  8 14.3% 






Q3UZG4 Aminoacyl tRNA synthase complex-interacting 
multifunctional protein 1  
4 21.3% 
Q3V1G4 Olfactomedin-like protein 2B  4 8.5% 
Q3V1L4 Cytosolic purine 5'-nucleotidase  10 28.4% 
Q3V3R1 Monofunctional C1-tetrahydrofolate synthase, 
mitochondrial  
2 3.0% 
Q497J0 MCG130175, isoform CRA_b  3 37.1% 
Q4LDD4 Arf-GAP with Rho-GAP domain, ANK repeat 
and PH domain-containing protein 1  
2 2.8% 
Q4QRL3 Coiled-coil domain-containing protein 88B  4 4.1% 
Q501J6 Probable ATP-dependent RNA helicase DDX17  7 13.2% 
Q543K9 Purine nucleoside phosphorylase  9 53.6% 
Q571E4 N-acetylgalactosamine-6-sulfatase  3 10.2% 
Q571I9 Aldehyde dehydrogenase family 16 member A1  8 14.5% 
Q5FWK3 Rho GTPase-activating protein 1  2 10.0% 
Q5RKN9 Capping protein (Actin filament) muscle Z-line, 
alpha 1  
9 52.5% 
Q5SQX6 Cytoplasmic FMR1-interacting protein 2  5 5.4% 
Q5SSW2 Proteasome activator complex subunit 4  2 2.2% 
Q5SUR0 Phosphoribosylformylglycinamidine synthase  10 14.4% 
Q5SUS9 RNA-binding protein EWS  3 7.1% 
Q5SXR6 Clathrin heavy chain  48 48.7% 
Q5XJF6 Ribosomal protein  4 22.6% 
Q60597 2-oxoglutarate dehydrogenase, mitochondrial  3 7.1% 
Q60605-2 Isoform Smooth muscle of Myosin light 
polypeptide 6  
8 77.5% 
Q60631 Growth factor receptor-bound protein 2  3 22.1% 
Q60668 Heterogeneous nuclear ribonucleoprotein D0  5 27.6% 
Q60692 Proteasome subunit beta type-6  8 65.6% 
Q60737 Casein kinase II subunit alpha  6 26.3% 
Q60749 KH domain-containing, RNA-binding, signal 
transduction-associated protein 1  
2 7.7% 
Q60864 Stress-induced-phosphoprotein 1  7 19.2% 
Q60865 Caprin-1  4 13.2% 
Q60963 Platelet-activating factor acetylhydrolase  9 35.0% 
Q60972 Histone-binding protein RBBP4  9 36.9% 
Q61024 Asparagine synthetase [glutamine-hydrolyzing]  5 12.1% 
Q61033 Lamina-associated polypeptide 2, isoforms 
alpha/zeta  
7 18.9% 
Q61035 Histidine--tRNA ligase, cytoplasmic  12 36.5% 
Q61081 Hsp90 co-chaperone Cdc37  2 9.8% 
Q61093 Cytochrome b-245 heavy chain  2 8.6% 




Q61166 Microtubule-associated protein RP/EB family 
member 1  
3 21.3% 
Q61171 Peroxiredoxin-2  6 57.1% 
Q61187 Tumor susceptibility gene 101 protein  2 11.8% 
Q61206 Platelet-activating factor acetylhydrolase IB 
subunit beta  
2 18.8% 
Q61233 Plastin-2  36 82.9% 
Q61362 Chitinase-3-like protein 1  5 24.2% 
Q61400 Carcinoembryonic antigen-related cell adhesion 
molecule 10  
2 19.6% 
Q61598 Rab GDP dissociation inhibitor beta  17 60.2% 
Q61599 Rho GDP-dissociation inhibitor 2  6 53.0% 
Q61635 GTP-binding protein  3 9.8% 
Q61646 Haptoglobin  12 53.3% 
Q61753 D-3-phosphoglycerate dehydrogenase  6 14.6% 
Q61768 Kinesin-1 heavy chain  3 4.5% 
Q61792 LIM and SH3 domain protein 1  2 10.7% 
Q61805 Lipopolysaccharide-binding protein  2 9.8% 
Q61881 DNA replication licensing factor MCM7  3 6.4% 
Q61937 Nucleophosmin  4 26.0% 
Q61990 Poly(rC)-binding protein 2  4 16.6% 
Q62093 Serine/arginine-rich splicing factor 2  2 11.3% 
Q62167 ATP-dependent RNA helicase DDX3X  8 16.5% 
Q62178 Semaphorin-4A  2 5.1% 
Q62318 Transcription intermediary factor 1-beta  4 10.8% 
Q62348 Translin  3 22.4% 
Q62376 U1 small nuclear ribonucleoprotein 70 kDa  5 16.5% 
Q62383 Transcription elongation factor SPT6  3 3.6% 
Q62393 Tumor protein D52  2 22.3% 
Q62418 Drebrin-like protein  6 22.0% 
Q62422 Osteoclast-stimulating factor 1  5 37.2% 
Q62431 AT-rich interactive domain-containing protein 
3A  
2 4.7% 
Q62465 Synaptic vesicle membrane protein VAT-1 
homolog  
6 24.6% 
Q62523 Zyxin  4 11.4% 
Q63810 Calcineurin subunit B type 1  4 52.4% 
Q63844 Mitogen-activated protein kinase 3  9 33.7% 
Q63918 Serum deprivation-response protein  2 6.0% 
Q64012 RNA-binding protein Raly  2 9.9% 
Q64152 Transcription factor BTF3  3 33.8% 




hydrolase 2  
Q64442 Sorbitol dehydrogenase  2 9.2% 
Q64511 DNA topoisomerase 2-beta  4 2.9% 
Q64514 Tripeptidyl-peptidase 2  12 15.9% 
Q64522 Histone H2A type 2-B  7 68.5% 
Q64674 Spermidine synthase  3 15.6% 
Q64727 Vinculin  32 47.0% 




bisphosphatase 4  
3 7.3% 
Q6IRU2 Tropomyosin alpha-4 chain  6 35.5% 
Q6NS79 Diap1 protein  7 11.3% 
Q6NSR8 Probable aminopeptidase NPEPL1  2 6.7% 
Q6NXH9 Keratin, type II cytoskeletal 73  3 6.5% 
Q6P069 Sorcin  8 48.5% 
Q6P2B1 Transportin-3  6 15.9% 
Q6P4T2 U5 small nuclear ribonucleoprotein 200 kDa 
helicase  
20 15.6% 
Q6P5E4 UDP-glucose:glycoprotein glucosyltransferase 1  26 31.1% 
Q6P5F9 Exportin-1  18 26.8% 
Q6P6I8 Signal-regulatory protein alpha  2 10.0% 
Q6PAV2 Probable E3 ubiquitin-protein ligase HERC4  2 3.5% 
Q6PD03 Serine/threonine-protein phosphatase 2A 56 kDa 
regulatory subunit alpha isoform  
7 25.7% 
Q6PDG5 SWI/SNF complex subunit SMARCC2  2 3.3% 
Q6PDI5 Proteasome-associated protein ECM29 homolog  6 7.0% 
Q6PDM2 Serine/arginine-rich splicing factor 1  4 23.8% 
Q6PDQ2 Chromodomain-helicase-DNA-binding protein 4  6 6.2% 
Q6PEB6 MOB-like protein phocein  2 23.1% 
Q6PFA2 Clathrin light chain A  3 17.9% 
Q6PHU5 Sortilin  2 2.9% 
Q6Q899 Probable ATP-dependent RNA helicase DDX58  3 6.3% 
Q6WVG3 BTB/POZ domain-containing protein KCTD12  6 24.2% 
Q6ZQ38 Cullin-associated NEDD8-dissociated protein 1  9 13.2% 
Q6ZQA0 Neurobeachin-like protein 2  8 5.5% 
Q6ZQK5 Arf-GAP with coiled-coil, ANK repeat and PH 
domain-containing protein 2  
4 8.8% 
Q6ZWM4 U6 snRNA-associated Sm-like protein LSm8  2 41.7% 
Q6ZWQ9 MCG5400  9 79.7% 
Q6ZWR6 Nesprin-1  17 3.4% 





Q6ZWY9 Histone H2B type 1-C/E/G  8 65.9% 
Q6ZWZ7 60S ribosomal protein L17  2 16.3% 
Q76MZ3 Serine/threonine-protein phosphatase 2A 65 kDa 
regulatory subunit A alpha isoform  
18 49.6% 
Q78PY7 Staphylococcal nuclease domain-containing 
protein 1  
11 21.7% 
Q78ZA7 Nucleosome assembly protein 1-like 4  4 15.2% 
Q792Z1 MCG140784  3 23.2% 
Q7M6Y3 Phosphatidylinositol-binding clathrin assembly 
protein  
3 6.8% 
Q7TMB8 Cytoplasmic FMR1-interacting protein 1  4 4.2% 
Q7TNG5 Echinoderm microtubule-associated protein-like 
2  
4 11.3% 
Q7TNV0 Protein DEK  5 16.3% 
Q7TPR4 Alpha-actinin-1  44 76.0% 
Q7TPV4 Myb-binding protein 1A  6 6.9% 
Q7TSI3 Serine/threonine-protein phosphatase 6 
regulatory subunit 1  
5 13.0% 
Q7TSV4 Phosphoglucomutase-2  2 4.8% 
Q80UI5 Phosphatidylinositol 3-kinase regulatory subunit 
alpha  
4 13.7% 
Q80UR4 Mast cell protease-11  3 12.9% 
Q80X41 Serine/threonine-protein kinase VRK1  6 19.1% 
Q80XR6 Heterogeneous nuclear ribonucleoprotein A/B  6 25.4% 
Q80YQ1 Thrombospondin 1  25 29.5% 
Q80ZJ2 Impa1 protein  4 21.0% 
Q810B6 Rabankyrin-5  2 4.5% 
Q8BFQ4 WD repeat-containing protein 82  2 10.9% 
Q8BFY6 Peflin  4 24.7% 
Q8BFZ3 Beta-actin-like protein 2  17 63.0% 
Q8BG32 26S proteasome non-ATPase regulatory subunit 
11  
9 32.9% 
Q8BGQ7 Alanine--tRNA ligase, cytoplasmic  8 16.3% 
Q8BH59 Calcium-binding mitochondrial carrier protein 
Aralar1  
2 7.2% 
Q8BH61 Coagulation factor XIII A chain  9 19.5% 
Q8BH69 Selenide, water dikinase 1  3 17.1% 
Q8BHD7 Polypyrimidine tract-binding protein 3  3 12.4% 
Q8BHN3 Neutral alpha-glucosidase AB  14 23.9% 
Q8BJS4 SUN domain-containing protein 2  4 6.7% 






Q8BK67 Protein RCC2  5 15.8% 
Q8BKC5 Importin-5  23 34.3% 
Q8BL97 Serine/arginine-rich splicing factor 7  3 15.7% 
Q8BMJ2 Leucine--tRNA ligase, cytoplasmic  3 4.4% 
Q8BMS1 Trifunctional enzyme subunit alpha, 
mitochondrial  
2 7.3% 
Q8BND5 Sulfhydryl oxidase 1  6 11.6% 
Q8BP47 Asparagine--tRNA ligase, cytoplasmic  9 24.7% 
Q8BPU7 Engulfment and cell motility protein 1  6 22.7% 
Q8BRF7 Sec1 family domain-containing protein 1  2 6.0% 
Q8BT60 Copine-3  10 25.5% 
Q8BTS0 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5  7 15.1% 
Q8BTZ7 Mannose-1-phosphate guanyltransferase beta  3 12.2% 
Q8BU30 Isoleucine--tRNA ligase, cytoplasmic  4 5.6% 
Q8BV13 COP9 signalosome complex subunit 7b  2 11.7% 
Q8BVE3 V-type proton ATPase subunit H  4 15.3% 
Q8BVG4 Dipeptidyl peptidase 9  3 6.2% 
Q8BVQ0 WD repeat-containing protein 61  3 25.1% 
Q8BWT1 3-ketoacyl-CoA thiolase, mitochondrial  6 30.5% 
Q8BWY3 Eukaryotic peptide chain release factor subunit 1  4 15.1% 
Q8BYA0 Tubulin-specific chaperone D  2 3.6% 
Q8C0E2 Vacuolar protein sorting-associated protein 26B  7 29.5% 
Q8C147 Dedicator of cytokinesis protein 8  11 9.0% 
Q8C166 Copine-1  4 8.8% 
Q8C1A5 Thimet oligopeptidase  2 6.4% 
Q8C1B7 Septin-11  4 13.2% 
Q8C266 Ras-related protein Rab-5C  4 24.8% 
Q8C3J5 Dedicator of cytokinesis protein 2  7 7.2% 
Q8C605 6-phosphofructokinase  3 7.3% 
Q8CC86 Nicotinate phosphoribosyltransferase  6 20.5% 
Q8CCK0 Core histone macro-H2A.2  3 14.8% 
Q8CDN6 Thioredoxin-like protein 1  3 20.8% 
Q8CFQ9 Fusion, derived from t(1216) malignant 
liposarcoma (Human)  
2 8.9% 
Q8CG29 Myosin IF  10 16.5% 
Q8CG48 Structural maintenance of chromosomes protein 
2  
2 2.7% 
Q8CGC7 Bifunctional glutamate/proline--tRNA ligase  12 13.6% 
Q8CGK3 Lon protease homolog, mitochondrial  2 7.3% 
Q8CGP0 Histone H2B type 3-B  7 56.4% 
Q8CGP4 Histone H2A  5 60.5% 





acetylglucosaminyltransferase 110 kDa subunit  
2 2.9% 
Q8CHP8 Phosphoglycolate phosphatase  2 9.7% 
Q8CI94 Glycogen phosphorylase, brain form  12 20.4% 
Q8CIH5 1-phosphatidylinositol 4,5-bisphosphate 
phosphodiesterase gamma-2  
28 34.6% 
Q8CIN4 Serine/threonine-protein kinase PAK 2  5 15.7% 
Q8CIZ8 von Willebrand factor  15 8.9% 
Q8CJG0 Protein argonaute-2  3 5.7% 
Q8JZQ9 Eukaryotic translation initiation factor 3 subunit 
B  
11 26.5% 
Q8K0E8 Fibrinogen beta chain  11 34.5% 
Q8K1B8 Fermitin family homolog 3  24 54.4% 
Q8K1K2 26S protease regulatory subunit 8  5 23.3% 
Q8K1M6 Dynamin-1-like protein  4 10.1% 
Q8K1X4 NCK associated protein 1 like  4 8.4% 
Q8K2Q0 COMM domain-containing protein 9  2 16.7% 
Q8K2Z4 Condensin complex subunit 1  4 5.8% 
Q8K411 Presequence protease, mitochondrial  2 3.6% 
Q8K426 Myeloid cysteine-rich protein  3 32.5% 
Q8K482 EMILIN-2  12 18.3% 
Q8K4Z5 Splicing factor 3A subunit 1  2 3.5% 
Q8QZW8 Protein Arhgap9  2 7.4% 
Q8QZY1 Eukaryotic translation initiation factor 3 subunit 
L  
15 37.6% 
Q8QZY6 Tetraspanin-14  2 10.4% 
Q8QZY9 Splicing factor 3B subunit 4  6 30.2% 
Q8R010 Aminoacyl tRNA synthase complex-interacting 
multifunctional protein 2  
4 33.1% 
Q8R016 Bleomycin hydrolase  9 42.2% 
Q8R0J7 Vacuolar protein sorting-associated protein 37B  3 21.8% 
Q8R146 Acylamino-acid-releasing enzyme  11 26.9% 
Q8R180 ERO1-like protein alpha  5 13.6% 
Q8R1B4 Eukaryotic translation initiation factor 3 subunit 
C  
11 15.9% 
Q8R1Q8 Cytoplasmic dynein 1 light intermediate chain 1  2 7.7% 
Q8R1V9 Protein Qars  3 13.9% 
Q8R2P8 Lysine--tRNA ligase  6 20.2% 
Q8R2S8 CD177 antigen  12 21.5% 
Q8R3C7 DEAD (Asp-Glu-Ala-Asp) box polypeptide 19b  2 7.7% 
Q8R5L1 Complement component 1 Q subcomponent-
binding protein, mitochondrial  
4 32.3% 




Q8VBV7 COP9 signalosome complex subunit 8  3 23.9% 
Q8VC88 Grancalcin  8 57.3% 
Q8VCI0 Phospholipase B-like 1  5 16.2% 
Q8VCM7 Fibrinogen gamma chain  12 43.8% 
Q8VCT3 Aminopeptidase B  8 23.1% 
Q8VDD5 Myosin-9  70 52.1% 
Q8VDL4 ADP-dependent glucokinase  3 12.7% 
Q8VDM4 26S proteasome non-ATPase regulatory subunit 
2  
23 43.5% 
Q8VDM6 Heterogeneous nuclear ribonucleoprotein U-like 
protein 1  
2 4.0% 
Q8VDP3 Protein-methionine sulfoxide oxidase MICAL1  2 2.6% 
Q8VDW0 ATP-dependent RNA helicase DDX39A  7 18.7% 
Q8VE37 Regulator of chromosome condensation  3 12.1% 
Q8VEK3 Heterogeneous nuclear ribonucleoprotein U  6 13.4% 
Q8VIJ6 Splicing factor, proline- and glutamine-rich  5 10.9% 
Q91V12 Cytosolic acyl coenzyme A thioester hydrolase  4 12.1% 
Q91V41 Ras-related protein Rab-14  5 39.5% 
Q91V89 Protein Ppp2r5d  2 5.9% 
Q91V92 ATP-citrate synthase  22 32.7% 
Q91VC3 Eukaryotic initiation factor 4A-III  7 25.6% 
Q91VH6 Protein MEMO1  2 11.5% 
Q91VI7 Ribonuclease inhibitor  8 30.3% 
Q91VW3 SH3 domain-binding glutamic acid-rich-like 
protein 3  
3 46.2% 
Q91WK2 Eukaryotic translation initiation factor 3 subunit 
H  
9 42.9% 
Q91WQ3 Tyrosine--tRNA ligase, cytoplasmic  4 11.4% 
Q91X72 Hemopexin  10 30.2% 
Q91XL1 Leucine-rich HEV glycoprotein  4 17.8% 
Q91YI4 Beta-arrestin-2  3 13.7% 
Q91YP3 Deoxyribose-phosphate aldolase  9 41.5% 
Q91YQ5 Dolichyl-diphosphooligosaccharide--protein 
glycosyltransferase subunit 1  
2 5.6% 
Q91YR9 Prostaglandin reductase 1  8 42.6% 
Q91Z50 Flap endonuclease 1  5 24.0% 
Q91Z69 SLIT-ROBO Rho GTPase-activating protein 1  2 2.2% 
Q91ZJ5 UTP--glucose-1-phosphate uridylyltransferase  13 41.3% 
Q91ZR2 Sorting nexin-18  2 11.1% 
Q91ZW3 SWI/SNF-related matrix-associated actin-
dependent regulator of chromatin subfamily A 
member 5  
2 2.6% 




Q921H8 3-ketoacyl-CoA thiolase A, peroxisomal  3 14.9% 
Q921I1 Serotransferrin  19 34.7% 
Q921M3 Splicing factor 3B subunit 3  24 33.9% 
Q921M7 Protein FAM49B  6 34.9% 
Q922B2 Aspartate--tRNA ligase, cytoplasmic  9 22.8% 
Q922D4 Serine/threonine-protein phosphatase 6 
regulatory subunit 3  
5 10.7% 
Q922D8 C-1-tetrahydrofolate synthase, cytoplasmic  3 4.6% 
Q922F4 Tubulin beta-6 chain  10 32.4% 
Q922H4 Mannose-1-phosphate guanyltransferase alpha  3 12.9% 
Q922R8 Protein disulfide-isomerase A6  8 28.4% 
Q922S4 cGMP-dependent 3',5'-cyclic phosphodiesterase  8 17.7% 
Q923D4 Splicing factor 3B subunit 5  3 43.0% 
Q923L6 Eosinophil-associated ribonuclease 10  2 19.9% 
Q924K8 Metastasis-associated protein MTA3  2 4.7% 
Q93092 Transaldolase  9 31.8% 
Q99J99 3-mercaptopyruvate sulfurtransferase  4 15.5% 
Q99JI4 26S proteasome non-ATPase regulatory subunit 
6  
8 29.3% 
Q99JI6 Ras-related protein Rap-1b  5 44.0% 
Q99JX4 Eukaryotic translation initiation factor 3 subunit 
M  
9 43.6% 
Q99JY9 Actin-related protein 3  19 72.3% 
Q99K48 Non-POU domain-containing octamer-binding 
protein  
4 13.7% 
Q99K85 Phosphoserine aminotransferase  2 8.9% 
Q99K94 Signal transducer and activator of transcription  8 16.4% 
Q99KE1 NAD-dependent malic enzyme, mitochondrial  9 27.8% 
Q99KI0 Aconitate hydratase, mitochondrial  6 12.4% 
Q99KJ8 Dynactin subunit 2  4 15.2% 
Q99KK7 Dipeptidyl peptidase 3  6 17.8% 
Q99KP6 Pre-mRNA-processing factor 19  6 28.2% 
Q99KQ4 Nicotinamide phosphoribosyltransferase  4 12.6% 
Q99KV1 DnaJ homolog subfamily B member 11  4 17.9% 
Q99L45 Eukaryotic translation initiation factor 2 subunit 
2  
4 19.9% 
Q99LB4 Capping protein (Actin filament), gelsolin-like  6 29.5% 
Q99LC5 Electron transfer flavoprotein subunit alpha, 
mitochondrial  
3 17.7% 
Q99LI7 Cleavage stimulation factor subunit 3  2 4.0% 
Q99LT0 Protein dpy-30 homolog  2 36.4% 




Q99NF7 Ppm1b protein  2 6.3% 
Q99P58 Ras-related protein Rab-27B  2 10.1% 
Q99PT1 Rho GDP-dissociation inhibitor 1  4 29.9% 
Q99PV0 Pre-mRNA-processing-splicing factor 8  13 10.5% 
Q9CPS5 26S proteasome non-ATPase regulatory subunit 
8  
2 15.9% 
Q9CPW4 Actin-related protein 2/3 complex subunit 5  5 61.6% 
Q9CPX6 Ubiquitin-like-conjugating enzyme ATG3  2 7.3% 
Q9CPY7 Cytosol aminopeptidase  3 10.6% 
Q9CQ19 Myosin regulatory light polypeptide 9  7 50.6% 
Q9CQ80 Vacuolar protein-sorting-associated protein 25  2 30.1% 
Q9CQE1 Protein NipSnap homolog 3B  4 28.7% 
Q9CQE8 UPF0568 protein C14orf166 homolog  3 20.5% 
Q9CQH7 Transcription factor BTF3 homolog 4  2 31.7% 
Q9CQI6 Coactosin-like protein  3 35.9% 
Q9CQR6 Serine/threonine-protein phosphatase 6 catalytic 
subunit  
4 24.3% 
Q9CQV8 14-3-3 protein beta/alpha  10 53.3% 
Q9CQW9 Interferon-induced transmembrane protein 3  2 20.4% 
Q9CR16 Peptidyl-prolyl cis-trans isomerase D  4 11.6% 
Q9CR57 60S ribosomal protein L14  2 11.5% 
Q9CR86 Calcium-regulated heat stable protein 1  2 35.1% 
Q9CRA5 Golgi phosphoprotein 3  2 12.4% 
Q9CS42 Ribose-phosphate pyrophosphokinase 2  2 10.1% 
Q9CU62 Structural maintenance of chromosomes protein 
1A  
4 4.3% 
Q9CVB6 Actin-related protein 2/3 complex subunit 2  16 77.3% 
Q9CW03 Structural maintenance of chromosomes protein 
3  
8 10.7% 
Q9CWJ9 Bifunctional purine biosynthesis protein PURH  16 47.1% 
Q9CXW3 Calcyclin-binding protein  2 13.1% 
Q9CXW4 60S ribosomal protein L11  2 12.9% 
Q9CXY6 Interleukin enhancer-binding factor 2  4 19.0% 
Q9CY58 Plasminogen activator inhibitor 1 RNA-binding 
protein  
2 7.9% 
Q9CYL5 Golgi-associated plant pathogenesis-related 
protein 1  
4 45.5% 
Q9CZ13 Cytochrome b-c1 complex subunit 1, 
mitochondrial  
3 15.6% 
Q9CZ30 Obg-like ATPase 1  4 18.7% 
Q9CZ44 NSFL1 cofactor p47  7 30.3% 
Q9CZD3 Glycine--tRNA ligase  5 13.2% 




Q9CZU6 Citrate synthase, mitochondrial  9 38.2% 
Q9D020 Cytosolic 5'-nucleotidase 3A  6 30.2% 
Q9D051 Pyruvate dehydrogenase E1 component subunit 
beta, mitochondrial  
2 8.4% 
Q9D0E1 Heterogeneous nuclear ribonucleoprotein M  4 9.2% 
Q9D0I9 Arginine--tRNA ligase, cytoplasmic  9 20.3% 
Q9D0R2 Threonine--tRNA ligase, cytoplasmic  13 24.4% 
Q9D154 Leukocyte elastase inhibitor A  15 54.4% 
Q9D1A2 Cytosolic non-specific dipeptidase  4 11.4% 
Q9D1K2 V-type proton ATPase subunit F  3 40.3% 
Q9D1Q6 Endoplasmic reticulum resident protein 44  5 23.2% 
Q9D2V7 Coronin-7  12 29.8% 
Q9D554 Splicing factor 3A subunit 3  5 20.8% 
Q9D662 Protein transport protein Sec23B  5 13.8% 
Q9D6J6 NADH dehydrogenase [ubiquinone] flavoprotein 
2, mitochondrial  
2 12.1% 
Q9D6R2 Isocitrate dehydrogenase [NAD] subunit alpha, 
mitochondrial  
5 21.0% 
Q9D6Y7 Mitochondrial peptide methionine sulfoxide 
reductase  
2 14.2% 
Q9D7M1 Glucose-induced degradation protein 8 homolog  3 29.4% 
Q9D819 Inorganic pyrophosphatase  3 15.6% 
Q9D883 Splicing factor U2AF 35 kDa subunit  2 13.0% 
Q9D8B3 Charged multivesicular body protein 4b  2 13.4% 
Q9D8N0 Elongation factor 1-gamma  10 41.0% 
Q9D8W5 26S proteasome non-ATPase regulatory subunit 
12  
7 18.0% 
Q9D964 Glycine amidinotransferase, mitochondrial  5 20.3% 
Q9DB05 Alpha-soluble NSF attachment protein  2 9.5% 
Q9DBC7 cAMP-dependent protein kinase type I-alpha 
regulatory subunit  
2 9.5% 
Q9DBG3 AP-2 complex subunit beta  21 39.7% 
Q9DBG5 Perilipin-3  2 8.5% 
Q9DBJ1 Phosphoglycerate mutase 1  10 69.3% 
Q9DBK7 MCG18845, isoform CRA_d  2 3.5% 
Q9DBZ5 Eukaryotic translation initiation factor 3 subunit 
K  
4 26.6% 
Q9DCC5 Cbx3 protein  4 39.3% 
Q9DCD0 6-phosphogluconate dehydrogenase, 
decarboxylating  
22 66.9% 
Q9DCH4 Eukaryotic translation initiation factor 3 subunit 
F  
6 31.0% 




Q9DCX2 ATP synthase subunit d, mitochondrial  2 21.7% 
Q9EPK7 Exportin-7  2 3.3% 
Q9EPL8 Importin-7  8 12.2% 
Q9EQG9 Collagen type IV alpha-3-binding protein  3 11.2% 
Q9EQH3 Vacuolar protein sorting-associated protein 35  19 37.9% 
Q9EQU5 Protein SET  5 35.0% 
Q9ER72 Cysteine--tRNA ligase, cytoplasmic  7 16.4% 
Q9ERD8 Gamma-parvin  5 23.3% 
Q9ERK4 Exportin-2  11 20.0% 
Q9ERL7 Glia maturation factor gamma  2 23.9% 
Q9ES46 Beta-parvin  2 8.8% 
Q9ES52 Phosphatidylinositol 3,4,5-trisphosphate 5-
phosphatase 1  
2 2.9% 
Q9ESP1 Stromal cell-derived factor 2-like protein 1  2 19.9% 
Q9EST5 Acidic leucine-rich nuclear phosphoprotein 32 
family member B  
2 10.7% 
Q9ET01 Glycogen phosphorylase, liver form  40 66.7% 
Q9JHJ0 Tropomodulin-3  3 17.6% 
Q9JHK5 Pleckstrin  6 35.7% 
Q9JHU4 Cytoplasmic dynein 1 heavy chain 1  24 9.0% 
Q9JI10 Serine/threonine-protein kinase 3  3 8.7% 
Q9JI11 Serine/threonine-protein kinase 4  3 9.5% 
Q9JIF0 Protein arginine N-methyltransferase 1  4 14.6% 
Q9JIF7 Coatomer subunit beta  10 18.2% 
Q9JIG7 Coiled-coil domain-containing protein 22  2 4.8% 
Q9JJ28 Protein flightless-1 homolog  13 21.3% 
Q9JKF1 Ras GTPase-activating-like protein IQGAP1  57 56.9% 
Q9JKR6 Hypoxia up-regulated protein 1  9 18.6% 
Q9JL26 Formin-like protein 1  7 10.2% 
Q9JLJ2 4-trimethylaminobutyraldehyde dehydrogenase  6 14.6% 
Q9JLV6 Bifunctional polynucleotide phosphatase/kinase  16 52.7% 
Q9JM14 5'(3')-deoxyribonucleotidase, cytosolic type  2 23.0% 
Q9JM76 Actin-related protein 2/3 complex subunit 3  6 50.0% 
Q9JMA1 Ubiquitin carboxyl-terminal hydrolase 14  6 19.9% 
Q9JMH6 Thioredoxin reductase 1, cytoplasmic  9 27.2% 
Q9QUG9 RAS guanyl-releasing protein 2  2 6.7% 
Q9QUH0 Glutaredoxin-1  2 38.3% 
Q9QUI0 Transforming protein RhoA  8 61.1% 
Q9QUM0 Integrin alpha-IIb  20 38.7% 
Q9QUM9 Proteasome subunit alpha type-6  10 52.0% 
Q9QUR6 Prolyl endopeptidase  7 16.1% 




Q9QXS1 Plectin  18 6.5% 
Q9QYB5 Gamma-adducin  3 5.0% 
Q9QZD9 Eukaryotic translation initiation factor 3 subunit 
I  
5 27.1% 
Q9QZE5 Coatomer subunit gamma-1  11 23.6% 
Q9QZK7 Docking protein 3  2 5.9% 
Q9QZQ8 Core histone macro-H2A.1  15 64.5% 
Q9QZU3 Platelet glycoprotein V (Fragment)  3 12.9% 
Q9R062 Glycogenin-1  10 63.7% 
Q9R0N0 Galactokinase  3 14.3% 
Q9R0P5 Destrin  7 55.2% 
Q9R0Q7 Prostaglandin E synthase 3  2 18.1% 
Q9R111 Guanine deaminase  20 72.7% 
Q9R190 Metastasis-associated protein MTA2  4 7.6% 
Q9R1P0 Proteasome subunit alpha type-4  8 57.5% 
Q9R1P1 Proteasome subunit beta type-3  5 40.5% 
Q9R1P3 Proteasome subunit beta type-2  7 64.2% 
Q9R1P4 Proteasome subunit alpha type-1  10 56.3% 
Q9R1T2 SUMO-activating enzyme subunit 1  2 9.4% 
Q9WTM5 RuvB-like 2  8 23.3% 
Q9WTX5 S-phase kinase-associated protein 1  3 27.6% 
Q9WTX6 Cullin-1  2 3.2% 
Q9WU00 Nuclear respiratory factor 1  2 10.1% 
Q9WU28 Prefoldin subunit 5  3 33.8% 
Q9WU78 Programmed cell death 6-interacting protein  15 31.1% 
Q9WUA2 Phenylalanine--tRNA ligase beta subunit  3 7.5% 
Q9WUM3 Coronin-1B  4 21.5% 
Q9WUM4 Coronin-1C  5 17.5% 
Q9WV32 Actin-related protein 2/3 complex subunit 1B  10 40.6% 
Q9WVA3 Mitotic checkpoint protein BUB3  5 23.6% 
Q9WVA4 Transgelin-2  8 56.8% 
Q9WVG5 Endothelial lipase  6 19.8% 
Q9WVJ2 26S proteasome non-ATPase regulatory subunit 
13  
10 47.9% 
Q9WVK4 EH domain-containing protein 1  18 59.9% 
Q9WVQ5 Methylthioribulose-1-phosphate dehydratase  3 19.1% 
Q9Z0I7 Protein Slfn1  3 13.1% 
Q9Z0M6 CD97 antigen  4 8.1% 
Q9Z0N1 Eukaryotic translation initiation factor 2 subunit 
3, X-linked  
6 26.3% 
Q9Z0P5 Twinfilin-2  8 41.3% 




Q9Z183 Protein-arginine deiminase type-4  14 37.1% 
Q9Z1B7 Mitogen-activated protein kinase 13  3 13.9% 
Q9Z1D1 Eukaryotic translation initiation factor 3 subunit 
G  
3 16.9% 
Q9Z1E4 Glycogen [starch] synthase, muscle  11 26.4% 
Q9Z1F9 SUMO-activating enzyme subunit 2  5 16.1% 
Q9Z1G3 V-type proton ATPase subunit C 1  2 8.9% 
Q9Z1N5 Spliceosome RNA helicase Ddx39b  10 35.3% 
Q9Z1Q5 Chloride intracellular channel protein 1  11 71.0% 
Q9Z1T1 AP-3 complex subunit beta-1  2 2.4% 
Q9Z1Z2 Serine-threonine kinase receptor-associated 
protein  
3 13.4% 
Q9Z204 Heterogeneous nuclear ribonucleoproteins 
C1/C2  
3 10.5% 
Q9Z2D6 Methyl-CpG-binding protein 2  2 8.1% 
Q9Z2I9 Succinyl-CoA ligase [ADP-forming] subunit 
beta, mitochondrial  
2 9.5% 
Q9Z2U0 Proteasome subunit alpha type-7  8 47.2% 
Q9Z2U1 Proteasome subunit alpha type-5  7 45.2% 
Q9Z2X1 Heterogeneous nuclear ribonucleoprotein F  6 24.6% 
S4R1I3 Xaa-Pro aminopeptidase 1  4 13.7% 
S4R1S4 Receptor-type tyrosine-protein phosphatase C  5 7.0% 
S4R2A9 Protein transport protein Sec31A (Fragment)  4 7.5% 
S4R2T5 Ubiquitin-like modifier-activating enzyme 
ATG7  
5 10.7% 
V9GX06 Uncharacterized protein (Fragment)  3 27.3% 












% Coverage GG peptide sequence 
A0A087WR50 71 56.4% GFNCESKPEPEETCFDK(GG) 
A2A841 2 3.9% TLNINGQVPTGDGPPLVK(GG) 
A2AE27 7 12.0% NSVLMSGFSHK(GG) 
A2AFF6 2 2.8% DPEEDGLMK(GG)R 
A2AH85 19 31.8% K(GG)MYSEIDIK(GG) 
A2AN08 2 0.8% LLLFICGSK(GG)EK(GG) 
A2AUR7 3 26.2% 
NQPEVDMSDRGISSMLDVNGLSVPPNVA
ELK(GG) 
A2AWT7 2 4.0% PDEIMRDYIQK(GG) 








B2RV77 4 53.6% AVEYKSQVVAGQNYFIK(GG) 








B9EJ54 4 3.0% K(GG)HK(GG)PDFISLFK 













D3Z6Q9 5 17.2% MAEGKAGGAAGLFAK(GG) 
D3Z7R7 7 11.8% AEEEQQGTGPGAGTAASKALDK(GG) 




E9PV60 2 1.2% ELTYVMLSTVVTLLQGSVRNAVVLK(GG) 
E9PVA8 3 2.2% CGLALALNK(GG) 
E9PWG6 2 3.0% INLLKETEQLEIK(GG) 
E9PZF0 9 48.3% PFFPGLVK(GG) 
E9Q035 19 24.7% GYYAVAVVKASDTSITWNNLK(GG) 










E9Q8H9 2 3.1% VYVQGQSLK(GG) 













E9QNN1 15 20.5% GMTLVTPLQLLLFASKK(GG) 
F6UND7 5 16.6% 
VAVKTMK(GG)PGSMSVEAFLAEANLMK
(GG) 
F6YVP7 4 24.3% K(GG)IAFAITAIK 














F8WHZ9 3 6.2% QDFNMMEQK(GG) 
F8WI35 5 60.0% 
FQSAAIGALQASEAYLVGLFEDTNLCAIH
AK(GG) 
G3UY93 12 18.6% SK(GG)DVVEPLLR 




G5E924 9 33.2% 
TENAGDQHGGGGGGGSGAAGGGGGEN
YDDPHK(GG) 
I7HPV9 2 2.8% 
TFVHPK(GG)AGAAGSLGAGLIPVSSELCY
R 
K3W4L0 3 3.1% DMLLAEAFSLKQQMEEK(GG) 
K3W4R2 6 4.1% INFDIAGYIVGANIETYLLEK(GG) 
O08582 3 8.1% PQQIKMQSTK(GG) 
O08739 11 26.4% ELQK(GG)ELAEQK(GG) 
O08992 7 58.5% MAPSIMK(GG) 
O09106 8 25.3% QQTDIAVNWAGGLHHAK(GG)K(GG) 
O09159 14 25.7% ATFDSGTGLLMK(GG) 
O35343 4 15.6% 
LLHSPHQNVCEQAVWALGNIIGDGPQCR
DYVISLGVVK(GG) 
O35955 2 14.7% MLK(GG)QAVEPTGGFSFENCQR 
O54774 2 2.8% VTYDIQASLQK(GG) 
O54824 3 4.0% ESSSTSSKEK(GG) 








O55222 8 25.0% DIVQKLLQYK(GG) 
O88307 17 11.3% 
STVFTIFGSNK(GG)ESVHSWLILQVNATD
ALGVPCTENDYK 


























O88783 3 1.9% NSYSGMK(GG) 
O88844 15 50.2% DIFQEIYDK(GG)K(GG) 
O88879 2 2.3% EDIKDYYTDLSILQK(GG) 
O89053 15 52.7% MSERQVALWDTK(GG) 
P02088 11 95.2% YFDSFGDLSSASAIMGNAK(GG) 







P04919 13 27.1% 
LIK(GG)IFQDYPLQQTYAPVVMKPKPQGP
VPNTALFSLVLMAGTFLLAMTLR 
P05064 16 77.2% PHPYPALTPEQK(GG)K 
P07724 18 40.6% GLVLIAFSQYLQKCSYDEHAK(GG) 
P07742 8 20.0% QGLK(GG)TGMYYLR 
P07759 4 17.7% AVLDVAETGTEAAAATGVIGGIRK(GG) 









P08003 13 33.4% EILTLK(GG)QVQEFLK(GG) 
P08113 9 18.2% SGTSEFLNK(GG) 
P09405 11 21.4% EAMEDGEIDGNKVTLDWAK(GG) 




P09542 2 12.3% 
AAAPK(GG)AAPAPAAAPAAAPAAAPEPE
RPK(GG) 










P10126 13 48.1% 
IGYNPDTVAFVPISGWNGDNMLEPSANM
PWFK(GG) 




P11499 23 50.4% EEEDKEDEEK(GG)PK 
P11835 16 33.6% LK(GG)SQWNNDNPLFK(GG) 






P13439 2 6.4% KFADIGNTVK(GG) 
P13864 3 3.8% RVVDTESGAAAAVEK(GG) 











P14824 10 22.3% LMLAVVK(GG) 
P16125 3 12.9% GYTNWAIGLSVADLIESMLK(GG) 




P17182 19 70.1% SGK(GG)YDLDFK(GG) 
P17427 16 30.1% WK(GG)QLSNPQQEVQNIFK(GG) 
P17710 6 9.5% GK(GG)FTTSDVAAIETDK(GG) 






P22682 2 3.0% 
K(GG)SSGAGGGGSGGSGAGGLIGLMK(G
G) 




P25206 5 12.4% DHQTITIQEMPEK(GG)APAGQLPR 
P25911-2 13 44.4% 
VAVK(GG)TLK(GG)PGTMSVQAFLEEAN
LMK 
P26039 72 50.3% MVEAAK(GG)GAAAHPDSEEQQQR 






















P28650 9 31.3% GHEWGVTTGRK(GG) 
P28665 5 6.8% FALEIPVEFSMVPMAK(GG) 




P30416 4 14.0% VKAEVAAGDHPTDAEMK(GG) 














P35980 3 19.7% ILEVPKLK(GG) 
P38647 5 10.5% EQQIVIQSSGGLSK(GG) 
P40124 16 57.4% VPTISINKTDGCHAYLSK(GG) 
P42227 8 20.9% FSESSK(GG)EGGVTFTWVEK(GG) 




P43274 6 33.8% KALAAAGYDVEK(GG) 
P43275 4 31.0% AK(GG)ASGAAK(GG) 








P45952 2 10.5% ENVLIGEGAGFK(GG) 
P47738 21 74.0% EEIFGPVMQILKFK(GG) 
P47791 14 57.6% 
GHILVDEFQNTNVK(GG)GVYAVGDVCG
K 
P47809 2 8.6% 
AAPSPSGGGGSGGGGGTPGPIGPPASGHP
AVSSMQGK(GG) 
P47955 3 72.8% INALIK(GG)AAGVSVEPFWPGLFAK(GG) 
P47962 5 21.2% ENPVYEK(GG)K(GG) 




























P51863 2 11.4% LLFEGAGSNPGDK(GG) 
P52480 23 69.3% K(GG)GVNLPGAAVDLPAVSEK 
P54987 2 10.5% MILDSLGVGFLGTGTEVFHK(GG) 
P57759 3 18.7% FDTQYPYGEK(GG)QDEFK 




P58252 28 51.2% EGIPALDNFLDK(GG) 
P60229 13 37.8% QLQAETEPIVK(GG) 




P61202 4 12.2% 
SINSILDYISTSKQMDLLQEFYETTLEALK(
GG) 





P62192 6 23.0% ESVELPLTHPEYYEEMGIK(GG) 
P62307 2 55.8% PFLNGLTGKPVMVK(GG)LK(GG) 











   
TVTAMDVVYALK(GG)R 
P62827 8 59.3% DGYYIQAQCAIIMFDVTSRVTYK(GG) 
P62960 5 31.4% 
PGSTGSGAGSGGPGGLTSAAPAGGDK(G
G) 
P63005 8 28.5% SPVTRVIFHPVFSVMVSASEDATIK(GG) 




P63158 7 40.0% LGEMWNNTAADDK(GG) 




P68433 6 60.3% 
FQSSAVMALQEACEAYLVGLFEDTNLCA
IHAK(GG) 
P68510 4 27.2% AVTELNEPLSNEDRNLLSVAYK(GG) 
P70168 21 44.1% 
DAAVMAFGSILEGPEPNQLKPLVIQAMPT
LIELMK(GG) 
P70195 9 55.2% LVSEAIAAGIFNDLGSGSNIDLCVISK(GG) 




P70290 4 13.7% QDK(GG)IAILDIEPQTLK(GG) 
P70336 3 3.8% DEEMSAAAIKAQFEK(GG) 







P70460 8 31.7% K(GG)MQPDQQVVINCAIIR 








P80318 14 38.4% K(GG)GESQTDIEITR 
P82198 21 57.3% K(GG)YFTNCK(GG) 











P97369 9 45.1% LLSDEDVGLMVK(GG) 
P99024 21 69.4% ISVYYNEATGGK(GG)YVPR 



















Q02053 32 53.8% YFLVGAGAIGCELLK(GG) 
Q03265 8 21.2% EPMQTGIK(GG) 
Q07076 7 23.3% QMFTQMYQK(GG)TLSTMIASDTSGDYR 
Q11011 23 38.8% 
AQELDALDNSHPIEVSVGHPSEVDEIFDAI
SYSK(GG)GASVIR 
Q3TXS7 14 29.9% 
TNLYQDDAVTGEAAGLALGLVMLGSK(G
G) 
Q3U898 2 71.9% 
MK(GG)PAVDEMFPEGAGPYVDLDEAGG
STGLLMDLAANEK 
Q3UKJ7 2 4.9% LIMQYLK(GG) 
Q3UMW7 2 8.1% EEMTSALATMRVDYDQVK(GG) 







Q3UZ39 5 11.7% 
PAEDSALSPGPLAGAK(GG)CEQQVQSQD
QENTSDLK 
Q3V1L4 10 28.4% GK(GG)DILYIGDHIFGDILK(GG) 
Q3V3R1 2 3.0% 
QAQFDIAVASEIMAVLALTDSLTDMK(GG
)ER 
Q4LDD4 2 2.8% QDARSVHLK(GG) 
Q4QRL3 4 4.1% EAPQGELVHK(GG) 
Q5SQX6 5 5.4% DK(GG)PANVQPYYLYGSK(GG) 
Q5SUS9 3 7.1% DFQGSKLK(GG) 






Q60668 5 27.6% K(GG)IFVGGLSPDTPEEK(GG) 
Q61599 6 53.0% LNYKPPPQK(GG) 












Q64514 12 15.9% 
RLNEIVDAANAVISHIDQTALAVYIAMK(
GG) 
Q64737 3 5.6% MLNIHPSLLPSFK(GG) 




Q6NS79 7 11.3% 
EKPNSAHRNSSASYGDDPTAQSLQDISDE
QVLVLFEQMLVDMNLNEEK(GG) 
Q6NXH9 3 6.5% AEAEMVYQTK(GG) 
Q6P2B1 6 15.9% RTEIIEDLAFYSSTVVSLLMTCVEK(GG) 
Q6P4T2 20 15.6% LDLVHTAALMLDK(GG) 
Q6P5F9 18 26.8% EFMKDTDSINLYK(GG) 
Q6PD03 7 25.7% EHWNQTIVALVYNVLKTLMEMNGK(GG) 
Q6PDG5 2 3.3% 
DIGEGNLSTAAAAALAAAAVK(GG)AK(G
G) 







Q6Q899 3 6.3% IMNESILRLQTWDEMK(GG) 
Q6ZQK5 4 8.8% LVVDAAK(GG) 



















Q6ZWX6 3 10.5% ENAEVDGDDDAEEMEAK(GG) 
Q78ZA7 4 15.2% VVIAEKEAATVEELNPK(GG) 
Q7TNV0 5 16.3% LLADANLEEVTMK(GG)QICK(GG) 
Q7TPR4 44 76.0% QYEKSIVNYKPK(GG) 
Q7TPV4 6 6.9% MLGVQRPK(GG)SEK 







Q8BKC5 23 34.3% LVLEQVVTSIASVADTAEEK(GG) 
Q8BMS1 2 7.3% 
IIDAVK(GG)AGLEQGSDAGYLAESQK(GG
) 
Q8BPU7 6 22.7% PSSLDQFK(GG) 
Q8BT60 10 25.5% IK(GG)NSLNPK(GG) 
Q8BU30 4 5.6% LFLNETQTQEITEDIPMK(GG) 
Q8BVE3 4 15.3% ELMEGSDLNYYFNWIK(GG) 
Q8BVG4 3 6.2% 
LVYFQGTK(GG)DTPLEHHLYVVSYESAG
EIVR 












Q8C1B7 4 13.2% KELEEEVSNFQK(GG) 
Q8C3J5 7 7.2% PQLLQENLEK(GG)LK 
Q8CG48 2 2.7% QVVIGGRNK(GG) 
Q8CGC7 12 13.6% EDIDAAVKQLLTLK(GG) 
Q8CGK3 2 7.3% LYK(GG)ALSLLK(GG) 
Q8CGP0 7 56.4% VLK(GG)QVHPDTGISSK 










Q8JZQ9 11 26.5% 
DRPQEADGIDSVIVVDNVPQVGPDRLEK(
GG) 
Q8K1K2 5 23.3% VDPLVSLMMVEK(GG) 
Q8K1M6 4 10.1% 
SK(GG)PIPIMPASPQK(GG)GHAVNLLDVP
VPVAR 







Q8K2Z4 4 5.8% ATEK(GG)VPSSPLER 





Q8QZY9 6 30.2% VSEPLLWELFLQAGPVVNTHMPK(GG) 
Q8R1Q8 2 7.7% 
K(GG)TGSPGGPGVGGSPGGGAAGASPSL
PPSAK(GG) 
Q8R2P8 6 20.2% MLSGMVK(GG)SITGSYK 























Q8VDM6 2 4.0% YNILGTNAIMDK(GG)MR 
Q8VIJ6 5 10.9% EEYEGPNK(GG)K(GG) 
Q91V92 22 32.7% LK(GG)QGLYR 
Q91VH6 2 11.5% IDQK(GG)IYGELWK(GG) 
Q91VI7 8 30.3% ELDLSNNCMGGPGVLQLLESLK(GG) 
Q91Z50 5 24.0% LIADVAPSAIRENDIK(GG) 
Q91Z69 2 2.2% DKEIIAEYESQVK(GG) 




Q91ZW3 2 2.6% ENMELEEKEK(GG) 
Q921H8 3 14.9% QDDFALASQQK(GG)AASAQSR 




Q922D8 3 4.6% MVVASSK(GG) 





Q93092 9 31.8% K(GG)FAADAIK 




Q99K94 8 16.4% 
FLEQVHQLYDDSFPMEIRQYLAQWLEK(
GG) 




Q99KV1 4 17.9% ITRPGAKLWK(GG) 
Q99L45 4 19.9% K(GG)TSFVNFTDICK(GG) 
Q99LB4 6 29.5% ESPIFK(GG)QFFK(GG) 




Q99MK8 5 14.1% GEVNAADAFDIGSFDEEDTKGIK(GG) 
Q99PV0 13 10.5% 
PADTEPPPLLVYK(GG)WCQGINNLQDVW
ETSEGECNVMLESR 
Q9CQR6 4 24.3% QCK(GG)YLPENDLK 
Q9CRA5 2 12.4% 
LLALIYLAHASDVLENAFAPLLDEQYDLA
TK(GG) 
Q9CS42 2 10.1% MVLVGDVK(GG) 




Q9CVB6 16 77.3% IIEETLALK(GG) 
Q9CW03 8 10.7% DLQDELAGNSEQRK(GG) 
Q9CWJ9 16 47.1% 
GAVDIPAAASFK(GG)HVSPAGAAVGVPL
SEDEAR 
Q9CZ44 7 30.3% SPGETSK(GG)PR 
Q9CZD3 5 13.2% DHPK(GG)FQSVADLCLYLYSAK(GG) 
Q9D0E1 4 9.2% 
GIGMGNLGPAGMGMEGIGFGINK(GG)IG
GMEGPFGGGMENMGR 
Q9D154 15 54.4% 
EQLSSANTLFALELFQTLNESSPTGNIFFSP
FSISSALAMVILGAKGSTAAQLSK(GG) 




Q9D8B3 2 13.4% LFGAGGGK(GG) 
Q9DBZ5 4 26.6% WLLAEMLGDLTDNQLK(GG)VWMSK 
Q9DCC5 4 39.3% IIGATDSSGELMFLMK(GG)WK(GG) 
Q9EQH3 19 37.9% NKLMDALK(GG) 
Q9ER72 7 16.4% MK(GG)IPPSEMFLSEVNK 
Q9ERD8 5 23.3% ILYSLFQK(GG) 
Q9ERK4 11 20.0% GSSTIATAAADK(GG) 









































Q9JI11 3 9.5% EISIMQQCDSPHVVK(GG)YYGSYFK 
Q9JIF0 4 14.6% 
AAAEAANCIMENFVATLANGMSLQPPLE
EVSCGQAESSEK(GG) 




Q9JJ28 13 21.3% CVYILDCWSDVFIWLGRK(GG) 










Q9QUM0 20 38.7% LAEVGRVYLFLQPK(GG) 
Q9QZD9 5 27.1% LGTYMGHTGAVWCVDADWDTK(GG) 





Q9R0P5 7 55.2% MIYASSK(GG)DAIK 
Q9R1P0 8 57.5% QDYK(GG)EGEMTLK 
Q9R1P1 5 40.5% SIMSYNGGAVMAMK(GG) 
Q9R1T2 2 9.4% VLIVGMKGLGAEIAK(GG) 
Q9WTM5 8 23.3% AAGVVLEMIREGK(GG) 
Q9WU78 15 31.1% K(GG)QEGLLK(GG) 
Q9WUM3 4 21.5% EAYVPSK(GG)QR 
Q9WUM4 5 17.5% NADPILISLKHGYIPGK(GG) 
Q9Z0N1 6 26.3% QATINIGTIGHVAHGK(GG) 





Q9Z1F9 5 16.1% 
SMAGNIIPAIATTNAVIAGLIVLEGLKILSG
K(GG) 
Q9Z1G3 2 8.9% VAQYMADVLEDSK(GG)DK(GG) 
Q9Z1N5 10 35.3% HFILDECDK(GG) 
Q9Z1Z2 3 13.4% PMLRQGDTGDWIGTFLGHK(GG) 
Q9Z2D6 2 8.1% KPGSVVAAAAAEAK(GG) 
Q9Z2U1 7 45.2% 
LNATNIELATVQPGQNFHMFTK(GG)EEL
EEVIK(GG) 
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